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List of abbreviations 
A/E Attaching and effacing lesion 
ABTS 2,2’-azino-di-(3-ethylbenzthiazoline sulfonate) diammonium salt 
AEC 3-amino-9-ethylcarbazole 
ASC Antibody-secreting cells 
AUC Area under the curve 
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TTSS Type III secretion system 
VTEC Verocytotoxic Eschericia coli 
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Escherichia coli (E. coli) is part of the commensal bacterial flora of the gastrointestinal 
tract of mammals and birds. Although E. coli lives in a symbiotic state with the host, some 
intestinal E. coli strains have acquired virulence factors that permit them to cause a wide range 
of enteric diseases. These pathotypes are found worldwide and pose serious medical and 
economical problems in developing and industrialized countries. The diarrhoeagenic E. coli 
strains are classified according to their virulence characteristics (Nataro and Kaper, 1998) 
(Figure 1). 
 
Figure 1: Overview of diarrhoeagenic E. coli (Adapted from Nataro and Kaper, 1998). 
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Enterotoxigenic E. coli (ETEC) is a major cause of travellers’ diarrhoea, diarrhoea in 
children and post-weaning disease in piglets. ETEC colonizes the small intestine by means of 
fimbriae, proteinaceous surface structures that mediate attachment to the intestinal epithelium. 
Colonization is followed by production of heat-stable and/or heat-labile toxins. The action of 
these enterotoxins causes inhibition of sodium chloride absorption by villus tip cells, resulting in 
osmotic diarrhoea (Nataro and Kaper, 1998).  
Enteropathogenic E. coli (EPEC) is a pathogen of the small intestine that causes severe 
watery diarrhoea, particularly among infants in developing countries. The hallmark of EPEC 
infection is the production of a typical histopathological lesion, the attaching and effacing (A/E) 
lesion. Bacteria attach firmly to the epithelial cells in the intestine, leading to local destruction of 
microvilli and formation of a pedestal underneath adherent bacteria (Knutton et al., 1989). The 
virulence factors responsible for this lesion are encoded on a pathogenicity island in the 
genome, the Locus of Enterocyte Effacement (LEE) (McDaniel et al., 1995). The most important 
of these factors is the eae-gene, encoding the intimin protein that mediates the intimate 
adhesion.  
Enterohaemorrhagic E. coli (EHEC) is a subgroup of Shiga toxin-producing E. coli (STEC), 
also named verocytotoxin-producing E. coli (VTEC), characterized by the production of Shiga 
toxins (Stx). STEC have one or more stx genes but do not necessarily cause disease, whereas 
EHEC strains are pathogenic for humans. EHEC causes diarrhoea, haemorrhagic colitis and the 
potentially fatal haemolytic uremic syndrome (HUS). EHEC strains are related to EPEC, sharing 
the ability to produce A/E lesions. Although many STEC serotypes have been associated with 
human illness, E. coli O157:H7 is by far the most frequently implicated serotype in sporadic cases 
and outbreaks worldwide (Nataro and Kaper, 1998). Ruminants constitute the major reservoir 
(Karmali, 1989). 
Enteroaggregative E. coli (EAEC) has been associated with acute and persistent diarrhoea 
in children, adults, travellers and immunocompromized individuals in developing and 
industrialized countries (Law and Chart, 1998). Where EPEC and EHEC adhere to intestinal 
epithelial cells in a localized manner, EAEC adhere in an aggregative, stacked brick pattern, with 
bacteria trapped in a mucus biofilm (Nataro et al., 1987). EAEC strains secrete entero- and 
cytotoxins, and induce mucosal inflammation (Nataro et al., 1995).  
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Diffusely adherent E. coli (DAEC) is a heterogeneous group of bacteria that attach to 
epithelial cells in a diffuse pattern, distinct from EAEC (Scaletsky et al., 1984). DAEC strains are 
associated with watery diarrhoea in children in different regions, but little is known about the 
pathogenic characteristics (Levine et al., 1993). DAEC can produce a wide range of adhesins, such 
as the family of afimbrial adhesins and the AIDA adhesin (Benz and Schmidt, 1989; Bilge et al., 
1989; Le Bouguenec and Servin, 2006). 
Enteroinvasive E. coli (EIEC) causes bacillary dysentery with high resemblance to the 
disease caused by the Shigella species (Nataro and Kaper, 1998). Bacteria invade the intestinal 
epithelial cells, followed by intracellular multiplication and dissemination to adjacent cells. Both 
Shigella and EIEC carry a large invasion plasmid and express a similar set of proteins. Infection is 
transmitted by direct contact from person to person or via contaminated food and water 
(Parsot, 2005). 
 
All mentioned pathotypes cause diarrhoea and have a large arsenal of virulence factors to 
subvert host cellular functions. However, the distinction between the different pathotypes is not 
always clear and more specifically, the relationship between STEC, EHEC and EPEC is complex. 
EHEC is thought to have evolved from an EPEC ancestor, E. coli O55:H7, and has gained 
pathogenicity through the acquisition of Shiga toxins and other virulence factors encoded on 
transposable bacteriophage elements and plasmids (Whittam et al., 1993; Lathem et al., 2003). 
Nevertheless, EHEC strains are not simply EPEC strains that produce Shiga toxins. Although EPEC 
and EHEC adhere in a similar manner, the adhesion factors and the mechanisms of this adhesion 
are not identical (Garmendia et al., 2005; Bardiau et al., 2010). This is best illustrated by the 
occurrence of different eae-types in EPEC and EHEC strains, and in other A/E pathogens 
(Ramachandran et al., 2003; Lacher et al., 2006). Furthermore, EPEC and EHEC both insert their 
own receptor, the translocated intimin receptor (Tir), into the host cell membrane, but the 
subsequent events leading to the formation of the A/E lesion are different, as well as the 
reportoire and function of the inserted virulence factors (Garmendia et al., 2005; Tobe et al., 
2006).  
 Additionally, the characterization of EHEC and STEC strains can be confusing. EHEC 
strains cause disease in humans and are best described as stx-positive and LEE-positive (as 
evidenced by the presence of the eae-gene) but also eae-negative STEC strains are known to 
cause HUS (Bonnet et al., 1998; Paton et al., 1999). On the other hand, it has been described that 
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EHEC strains can loose the ability to produce Shiga toxins during disease progression or during 
subculturing although they were initially isolated from patients diagnosed with EHEC-induced 
HUS (Schmidt et al., 1999; Bielaszewska et al., 2009). 
This literature review focuses on E. coli O157:H7, although much knowledge is derived 
from research performed with STEC and EPEC strains, and even Citrobacter rodentium 
(C. rodentium), a related A/E mouse pathogen that functions as a model for human EHEC 
infection (Schauer and Falkow, 1993). 
2. E. coli O157:H7 in humans 
2.1. Pathogenesis 
After having survived the acidic environment of the stomach, E. coli O157:H7 adheres to 
the intestinal epithelium leading to A/E lesion formation, destruction of microvilli and induction 
of inflammation. Colonization is followed by release of Stx, which leads to damage to the 
mucosal endothelium. It is still unclear how Stx produced in the intestinal lumen is transported 
to the small blood vessels. Probably, the toxin is translocated through the epithelial cells into the 
circulation (Acheson et al., 1996), although the presence of the Stx receptor has not been 
detected on human enterocytes. Inflammation of the colonic mucosa is seen in E. coli O157:H7-
infected patients, and it has been proposed that mucosal damage generates a way for Stx to 
cross the epithelial barrier (Gobert et al., 2008). Once in the circulation, there is evidence that 
Shiga toxin is transported by polymorphonuclear leucocytes to the kidneys although this is the 
subject of debate (te Loo et al., 2000; Geelen et al., 2007). Subsequently, Stx is internalized in the 
target-cells via binding to its receptor globotriaosylceramide (Gb3) (Lingwood, 1993). The action 
of Stx on the endothelial cells of the small capillaries causes the characteristic haemorrhages. 
Furthermore, the concerted action of several virulence factors (discussed further below) causes 
extensive mucosal damage. 
2.2. Clinical manifestations 
The infectious dose for humans is presumably very low since an ingestion of less than 100 
bacteria can cause an infection (Lin et al., 1996). After ingestion of the bacteria, there is an 
incubation period of typically 3-4 days. Infection with E. coli O157:H7 is characterized by the 
sudden onset of severe abdominal cramps and watery diarrhoea that progresses rapidly to 
bloody diarrhoea (haemorrhagic colitis). The diarrhoea usually lasts 1-8 days. Vomiting can 
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occur, but fever is often absent (Riley et al., 1983; Su and Brandt, 1995; Coia, 1998). The 
infection can be complicated by a potentially life-threatening illness, HUS. HUS is characterized 
by thrombocytopenia (low platelet counts), microangiopathic haemolytic anaemia (anaemia due 
to damaged blood vessels leading to destruction of red blood cells, causing fatigue and 
weakness) and acute kidney failure. Some patients with HUS also develop complications of nerve 
or brain damage, such as seizures or strokes. Patients often need dialysis and are at risk of 
developing long-term sequelae (Siegler et al., 1994), while 3-12% percent of HUS-patients die 
(Garg et al., 2003; Siegler, 2003). HUS typically presents a few days after the onset of acute 
diarrhoeal illness and affects especially young children, elderly people and immunocompromized 
patients (Karmali et al., 1985; Griffin et al., 1988; Tarr et al., 2005; Gould et al., 2009). HUS and 
haemorrhagic colitis are caused by the action of Stx released by E. coli O157:H7 on blood vessels 
in the kidney and the intestine. Treatment of E. coli O157:H7 infections includes rehydration 
therapy and is mainly symptomatic and supportive (Griffin et al., 1988; Tarr, 1995). Anti-motility 
agents are contra-indicated (Tarr and Neill, 2001). Use of antibiotics remains controversial as 
bacterial lysis can lead to increased Stx release (Kimmitt et al., 2000; Kohler et al., 2000; Tarr et 
al., 2005) but not all studies agree on the adverse effects of particular antibiotics (Grif et al., 
1998; Shiomi et al., 1999; Panos et al., 2006).  
2.3. Incidence 
Since the initial reports (Riley et al., 1983), sporadic cases and outbreaks of E. coli 
O157:H7 infection have been increasingly reported, which can partly be explained by improved 
detection methods and increased surveillance. Worldwide, reported annual rates of E. coli 
O157:H7 infections vary greatly, with incidence numbers per 100,000 inhabitants of 4.6 cases in 
Scotland (Health protection Scotland, 2010), 1.5 in the U.S. (Gould et al., 2009) and 0.9 in 
Australia (McPherson et al., 2009). Rates in Scotland tend to be higher than in most other 
European and North-American countries (Pearce et al., 2009). Argentina has the highest 
worldwide incidence of reported HUS cases in children younger than five year of age, with 12.2 
cases per 100,000 children (Rivas et al., 2008). Reported HUS rates are 1.42 cases per 100,000 
children younger than 16 in Switzerland (Schifferli et al., 2009) and 4.3 per 100,000 children 
under 5 years of age in Belgium (Cornu et al., 1999). Most cases are sporadic, but larger 
outbreaks have often been associated with E. coli O157:H7, such as the spinach outbreak in 2006 
in the U.S., with 238 infected persons (Centers for Disease Control and Prevention, 2009). The 
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largest E. coli O157:H7 outbreak occurred in Japan and involved more than 6,000 children on a 
total of 12,860 diagnosed cases (Michino et al., 1999). Although STEC infections mostly occur in 
developed countries, outbreaks have been reported taking place in African countries as well 
(Germani et al., 1997; Cunin et al., 1999; Effler et al., 2001). 
According to the most recent available data from the European Food Safety Authority 
(EFSA) 3,159 cases of STEC infections occurred in 2008 in the European Union (EU) member 
states (Table 1). Fifty-three percent of these cases were caused by serotype O157:H7 (European 
Food Safety Authority, 2010). 
 
Table 1: Confirmed STEC cases reported by European countries in 2008. 
Country Incidence per 100,000 
inhabitants 
Cases 
Austria 0.8 69 
Belgium 1.0 103 
Bulgaria 0 0 
Cyprus 0.3 2 
Czech Republic - - 
Denmark 2.9 161 
Estonia 0.2 3 
Finland 0.2 8 
France 0.1 85 
Germany 1.1 876 
Greece 0 0 
Hungary 0 0 
Ireland 4.8 213 
Italy < 0.1 24 
Latvia 0 0 
Lithuania 0 0 
Luxembourg 0.8 4 
Malta 1.9 8 
Netherlands 0.6 92 
Poland < 0.1 3 
Portugal - - 
Romania < 0.1 4 
Slovakia 0.1 8 
Slovenia 0.3 7 
Spain < 0.1 21 
Sweden 3.3 304 
United Kingdom 1.9 1164 
EU total 0.7 3159 
Iceland 1.3 4 
Liechtenstein 0 0 
Norway 0.5 22 
Switzerland 0.9 67 
Adapted from EFSA (2010) 
Literature review 
15 
It is important to note that the reported data are likely an underestimation of the true 
incidence, since STEC infections are not notifiable in all countries, laboratory isolation methods 
differ between countries, not all laboratories screen routinely for STEC, and many infections pass 
unnoticed, or are mild, without the need for medical attention. Although the incidence is low 
compared to the two most important foodborne infections, Campylobacter and Salmonella 
(European Food Safety Authority, 2010), STEC infections and E. coli O157:H7 in particular, are 
considered important due to the severity of the illness and the high case-fatality rate (Coia, 
1998). 
3. Animal reservoir 
3.1. Epidemiology 
E. coli O157:H7 was first recognized as a foodborne pathogen after an outbreak of 
haemorrhagic colitis in the U.S. in 1982, caused by consumption of undercooked hamburgers 
(Riley et al., 1983). At the same time, the link between presence of Stx in faeces of patients and 
HUS was established (Karmali et al., 1983). Since then, the pathogen has been recognized as a 
zoonotic agent, spread by animals to humans by the faecal-oral route. Ever since the first human 
outbreak was linked with ground beef consumption a bovine reservoir was suspected. Indeed, 
cattle have been identified as the most important reservoir (Karmali, 1989). During slaughter, 
the bacteria can be transmitted from the hide and the intestines to the carcass, and may cause a 
foodborne infection when the meat is not sufficiently heated prior to consumption. This is not 
the only route of transmission, an E. coli O157:H7 infection can occur through consumption of a 
wide variety of contaminated foods, including unpasteurized juice, raw milk, and raw produce 
(e.g., lettuce, spinach, and alfalfa sprouts) (Caprioli et al., 2005) and even fermented products 
(Conedera et al., 2007). Outbreaks have been linked to contaminated drinking water or 
recreational water (Paunio et al., 1999; Bruce et al., 2003; Richards, 2005). Direct contact with 
animals on farms and on contaminated pastures have also resulted in outbreaks of infection 
(Caprioli et al., 2005) and person-to-person spread to family members or in child-care settings 
have caused secondary cases of infection (Al-Jader et al., 1999; Galanis et al., 2003). However, 
E. coli O157:H7 does not always result in clinical illness, as evidenced by the isolation of the 




Cattle are considered to be the major reservoir of E. coli O157:H7, harbouring the 
bacteria in their gastrointestinal tract without developing clinical symptoms as seen in humans. 
Occasionally, E. coli O157:H7 has been associated with diarrhoea in young calves and diarrhoea 
can be induced by experimental infection with E. coli O157:H7 (Dean-Nystrom et al., 1997; Dean-
Nystrom et al., 1999; Kang et al., 2004), but the susceptibility of calves to E. coli O157:H7 
diarrhoea decreases with age (Mechie et al., 1997; Shinagawa et al., 2000; Nielsen et al., 2002).  
Occurrence of E. coli O157:H7 is very common in cattle. Estimates of prevalence range 
from 0 to 71% of individual animals and from 0 to 100% of herds, and involve reports from 
countries worldwide (reviewed by Gyles, 2007). A recent study demonstrated a farm prevalence 
of 37.8% in Belgian cattle farms (Cobbaut et al., 2009), where the proportion of cattle being 
positive within a farm ranged from 0 to 85% (Cobbaut et al., 2008). In a large-scale study 
performed in Scotland from 1998 until 2000, 207 out of 952 sampled farms (21.7%) were found 
to be positive for E. coli O157:H7 (Pearce et al., 2009). A Dutch study based on sampling of 1051 
dairy herds and 930 veal herds revealed a herd-level prevalence of 8 and 12% for dairy and veal 
herds respectively (Berends et al., 2008). In the U.K., the within-herd prevalence of E. coli 
O157:H7 ranged from 0 to 60% (mean 24%) when 30 groups of young cattle on 30 farms were 
observed for 7 months and sampled on 4 to 6 separate occasions (Ellis-Iversen et al., 2009). The 
overall prevalence of cattle at slaughter in Kansas, U.S., was 20.3%, determined by the presence 
of  E. coli O157:H7 in at least one intestinal site (Walker et al., 2010). Seventy-one percent of 
cattle arriving in small-scale U.S. processing plants had E. coli O157:H7 on the hide, whereas 33% 
of the pre-evisceration carcasses were positive. Only 2% of these carcasses had E. coli O157:H7 
levels higher than 0.8 CFU/100 cm2 (Bosilevac et al., 2009). The contrast between the prevalence 
before and after slaughter is also evident in Argentina where 10.5% of the calves were positive 
compared to 2.6% of carcasses (Masana et al., 2010).  
Not only cattle but small ruminants as well are a reservoir for E. coli O157:H7. The 
bacteria  have been isolated from sheep (Kudva et al., 1996, 1997a), goats (Pritchard et al., 2000; 
Orden et al., 2010) and wild ruminants  (Renter et al., 2001; Garcia-Sanchez et al., 2007; Sanchez 
et al., 2010). Prevalence rates for individual sheep based on examination of faecal samples 
varied from 0 to 7.3% in different studies conducted in Europe and the U.S. (Sutherland et al., 
2009; Oporto et al., 2008; Franco et al., 2009; Solecki et al., 2009).  
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Apart from being isolated from ruminants, E. coli O157:H7 has also been found 
sporadically in a wide variety of animals including pigs, horses, poultry and companion animals 
(Trevena et al., 1996; Doane et al., 2007; Feder et al., 2007; Pritchard et al., 2009). These animals 
are generally not regarded as a reservoir but can be a natural source of E. coli O157:H7 and 
therefore pose a risk to the public health. 
Literature searches reveal that reported prevalence rates vary greatly, and many factors 
can influence the results: the used detection method (direct culture or enrichment with 
immunomagnetic separation, the culture medium and agar plates, PCR-based detection 
methods,...), the type of samples (faecal samples, rectal swabs, environmental samples, hide or 
carcass swabs,...), the sampling method (single sample or longitudinal study), testing individual 
animals or testing at the herd level, age of the animals, the farm type, seasonal variation etc. 
Therefore, reported rates are probably an underestimation of the true prevalence of E. coli 
O157:H7. In addition, the duration of shedding of E. coli O157:H7 by naturally infected cattle is 
highly variable. The length of the observed shedding is influenced by the detection method, with 
sensitive methods more likely to detect longer periods of shedding. Longitudinal studies have 
shown that shedding of E. coli O157:H7 is transient (Smith et al., 2010). Three distinct patterns 
were reported by several authors: non-persistent shedding lasting not more than 7 days, 
moderately persistent shedding lasting approximately one month, or persistent shedding lasting 
several months to even a year (Rice et al., 2003; Robinson et al., 2004; Baines et al., 2008). 
Natural fluctuations within an animal over time may be caused by intrinsic factors such as gut 
flora, gut health, behaviour or other anatomical, physiological or physical stresses (Robinson et 
al., 2009) or by external factors. Indeed, the risk of detecting E. coli O157:H7 was almost five 
times higher when the cattle were housed indoors compared to cattle grazing of pasture (Ellis-
Iversen et al., 2009). Influence of diet has been reported (reviewed by Jacob et al., 2009). 
Shedding also appears to be related to weaning and age. Lowest rates were reported in calves 
before weaning, highest rates occurred in the post-weaning period and levels in adult cattle 
were intermediate (Mechie et al., 1997; Shinagawa et al., 2000; Nielsen et al., 2002). The 
prevalence of E. coli O157:H7 is low in winter, increases during spring and peaks in the warm 
summer months (Hancock et al., 1997; Tutenel et al., 2002). 
A small proportion of cattle shed high levels of E. coli O157:H7 and have great potential 
to transmit the bacteria to other animals in the herd. These so-called supershedders excrete 
more than 103 CFU/g, and do so for longer periods of time (Omisakin et al., 2003; Low et al., 
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2005; Matthews et al., 2006b). It is unknown why certain animals become supershedders 
whereas others do not. 
3.3. Survival of E. coli O157:H7 in the environment 
Besides the production of Shiga toxins, the highly virulent character of E. coli O157:H7 is 
associated with the fact that this bacterium can survive in harsh conditions and can grow at 
temperatures between 6 and 45,5°C, in a pH range of 4,4 to 9,0 and water activities between 
0,95 and 0,99 (Raghubeer and Matches, 1990; Clavero and Beuchat, 1996; Ferenc et al., 2000; 
Echeverry et al., 2006). Thus, E. coli O157:H7 excreted into the environment appears to be well 
adapted to survive in different matrices such as water, soil and animal faeces, for periods 
ranging from several weeks to several months (Echeverry et al., 2006; Ibekwe et al., 2007; Avery 
et al., 2008). E. coli O157 even has the capacity to survive and to replicate in different bedding 
materials in the presence of urine (Conedera et al., 2001; Davis et al., 2005; Lejeune and 
Kauffman, 2005). In a study performed in Belgium, samples from the pen floor were positive for 
E. coli O157 on six sampling occasions whereas the pathogen was not detected in the faeces 
from the animals staying in the pen (Cobbaut et al., 2008). Manure from cattle production 
facilities can contain viable E. coli O157:H7, thus providing a source of human infection by 
contamination of the water supply or produce when it is used as fertilizer or as irrigation water 
on crops (Callaway et al., 2009). 
3.4. Tissue tropism 
The observation that E. coli O157:H7 could hardly be isolated from contents along the 
gastrointestinal tract of naturally infected cattle despite being abundantly present in faeces from 
(103 to 105 CFU/g) has led to the discovery of the terminal rectum as a primary colonization site 
in cattle (Grauke et al., 2002; Naylor et al., 2003). The majority of tissue-associated bacteria were 
recovered from the recto-anal junction (RAJ) of persistently colonized cattle following natural 
and experimental infection (Naylor et al., 2003). In contrast, non-pathogenic E. coli were present 
throughout the gastrointestinal tract and were mostly associated with digesta rather than the 
mucosa (Laven et al., 2003; Naylor et al., 2003). Factors that drive the tropism for the rectum are 
mostly unknown. Naylor et al. (2003) suggested that the tropism for this site may be related to 
the presence of lymphoid follicles in the RAJ, since other members of the Enterobacteriaceae, 
e.g., Salmonella enterica serovar Typhimurium, Listeria monocytogenes, Shigella and Yersinia 
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species have well-described tropisms for Peyer's patches, another region of gut-associated 
lymphoid tissue and known induction sites of immune responses. However, Lim et al. (2007a) 
stated that this can not be the sole reason for the rectal tropism, as E. coli O157:H7 does not 
colonize other tissues rich in lymphoid tissue. Nevertheless, it is interesting that E. coli O157:H7 
colonizes a site where it can interact immediately with the host immune system, especially since 
the bacterium is known to influence immune responses (discussed further).  
More likely is a receptor-based tropism. There is evidence that intimin-γ, an important 
factor mediating adherence that is specific for E. coli O157:H7, shows more restricted tissue 
affinity than other intimin types (Hartland et al., 2000). Complementation of an intimin-γ mutant 
of E. coli O157:H7 with intimin-α from an EPEC strain resulted in altered tissue tropism, namely 
colonization of both the large and small intestine, as normally seen in EPEC (Tzipori et al., 1995). 
Intimin-γ binds not only to its specific receptor Tir that is inserted into the host membrane by the 
bacteria itself, but also binds to the host receptors β1-integrin and nucleolin (Sinclair et al., 
2006). Differential expression of these receptors along the gastrointestinal tract could play a role 
in the rectal tropism but remains to be determined. Moreover, E. coli O157:H7 might be able to 
influence the expression of the host receptors at the terminal rectum: it is known that Stx2 can 
increase the expression of nucleolin on HEp-2 cells (Robinson et al., 2006). A second adhesion 
based hypothesis involves StcE, a metalloprotease secreted by E. coli O157:H7. Grys et al.  (2005) 
have demonstrated that StcE promotes intestinal adherence by cleaving glycoproteins in the 
mucus layer, bringing the bacteria in closer contact with the cell surface. This could in turn lead 
to a reduction of commensal bacteria in the proximity, thereby providing an advantage for E. coli 
O157:H7 to compete for space and nutrients. 
Besides receptor-based mechanisms, there could be a physiological and biochemical basis 
for the observed tissue tropism. Since the concentration of NaHCO3 in the lower intestinal tract 
is relatively high compared to the concentration in the upper small intestine, the NaHCO3 may be 
an important signalling factor for promoting colonization of EHEC in the lower intestinal tract of 
humans (Abe et al., 2002). Another possibility is a nutritional basis for the rectal tissue tropism: 
bovine intestinal mucins contain L-fucose, which could be a preferred nutrient for E. coli 
O157:H7. A mutant E. coli O157:H7 strain unable to catabolise L-fucose exhibited significantly 
less colonization than the wild type strain as measured in faecal and rectal mucus samples 
(Snider et al., 2009). Spatial differences in availability of L-fucose or other sugars might explain 
the rectal tissue tropism. The composition of bovine rectal mucins is yet unknown. Other 
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proposed mechanisms include differences in lower volatile fatty acid concentrations, higher pH, 
mucus production etc., leading to more favourable conditions for survival and growth of E. coli 
O157:H7 in the rectum compared to other intestinal sites (Fox et al., 2007). 
Finally, an animal can harbour different E. coli O157:H7 strains and certain strains might 
be better adapted to colonization in the rectum than others, which merely pass the intestine and 
only cause a transient shedding (Fox et al., 2008). 
A difficulty in determining the exact mechanism behind the rectal tissue tropism is the 
detection limit of adherent bacteria in histological sections. E. coli O157:H7 counts of 105 to 106 
per cm2 are deemed necessary for demonstrating bacterial adherence (Bertschinger et al., 1972; 
Nart et al., 2008b). 
4. Options for the control of E. coli O157:H7 in ruminants 
After the outbreak in 1982 was traced to contaminated hamburgers, it became obvious 
that meat should be sufficiently cooked before consumption to kill pathogenic bacteria that 
might be present. In recent years, it has become apparent that contaminated meat is far from 
the only source for E. coli O157:H7 infection, substantiating the need for efficient control 
strategies. Decontamination processes are implemented to reduce the pathogen burden on 
carcasses, and many other methods are studied to control E. coli O157:H7 in ruminants. Because 
E. coli O157:H7 is widespread on cattle farms throughout the world and it can be isolated from 
many animal species, complete eradication is not realistic. It has been calculated that pre-
harvest interventions that reduce the prevalence of E. coli O157:H7 in faeces will lead to fewer 
human infections (Jordan et al., 1999). Moreover, the strategic targeting of supershedders would 
drastically reduce the transmission of E. coli O157:H7 between herds and within slaughterhouses 
(Matthews et al., 2006a). 
4.1. Exposure reduction strategies 
Fairly simple management practices on the farm and in slaughterhouses are important 
and have the potential to reduce the general bacterial contamination (LeJeune and Wetzel, 
2007). Good management practices ensure hygienic conditions on the farm and can reduce the 
prevalence of E. coli O157:H7. These measures include providing clean pens, clean water 
troughs, and dry bedding to cattle, but also maintaining animals in the same group, keeping 
calves separate from older animals and excluding the cattle population from wildlife (LeJeune 
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and Wetzel, 2007; Ellis-Iversen et al., 2008). Visibly dirty animals and stables tend to have higher 
E. coli O157:H7 rates (Nastasijevic et al., 2008). On the other hand, an animal does not have to 
be intestinally colonized to have a contaminated hide or vice versa (Van Donkersgoed et al., 
1997; Reid et al., 2002). Transfer of bacteria from one animal to another can occur during 
transport to the slaughterhouse, leading not only to contamination of more animals brought into 
the slaughterhouse, but also contamination of the transport vehicle (Arthur et al., 2007a; Cuesta 
Alonso et al., 2007). In the slaughterhouse, much of the bacterial contamination of the carcass 
occurs during removal of the hide (Madden et al., 2004). Good slaughtering practices like 
cleaning knives and washing hands in between carcasses may prevent further contamination. 
Decontamination measures such as washing procedures or the use of organic acids, are 
implemented on the carcasses, but have not always been shown to be effective (Bosilevac et al., 
2006; Arthur et al., 2007b; Penney et al., 2007; Laury et al., 2009). Furthermore, chemical 
decontamination may lead to discolouration of the carcass, affecting the consumer’s concern 
towards meat. 
4.2. Feed management 
Other strategies aim at modifying the gastrointestinal flora of ruminants to prevent 
establishment or to remove E. coli O157:H7. The type of feed (grain, hay) given to cattle appears 
to have an influence on prevalence and shedding (reviewed in Jacob et al., 2009). Berg et al. 
(2004) reported higher E. coli O157:H7 concentrations in cattle on a barley grain diet than in 
cattle on a corn-based diet, and shedding was decreased in sheep that were switched from a 
grass diet to an alfalfa diet (Kudva et al., 1997b). Following dietary changes or withholding feed, 
animals that appeared to be culture negative started excreting E. coli O157:H7 (Kudva et al., 
1995). The mechanisms behind the effect of diet on E. coli O157:H7 prevalence is poorly 
understood but include changes in volatile fatty acid concentrations, pH changes in the rumen 
and altering the residual microflora (Jacob et al., 2009). Apart from the type of feed having an 
influence on the prevalence, the feed itself may be contaminated with E. coli O157:H7 (Lynn et 
al., 1998).  
4.3. Probiotics 
Probiotics are live, non-pathogenic micro-organisms that confer a health benefit to the 
host. Probiotics (also named “direct-fed microbials”) have been used in the cattle industry for 
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over 20 years to enhance animal health and production, and are more recently investigated as a 
means to reduce foodborne pathogens in animals, including E. coli O157:H7. Pseudomonas 
aeruginosa strains inhibitory to E. coli O157:H7 have been isolated from the rumen of sheep 
(Duncan et al., 1999), and E. coli strains isolated from healthy cattle reduced the excretion of 
serotype O157:H7 in experimentally infected cattle by producing colicins (Zhao et al., 1998; 
Schamberger et al., 2004). Lactobacillus strains have shown considerable promise in reducing 
intestinal colonization and faecal shedding of E. coli O157:H7 in experimentally infected calves 
(Ohya et al., 2000) and sheep (Lema et al., 2001), and several large studies have confirmed the 
potential of probiotics to reduce EHEC shedding in weaned calves and harvest-ready feedlot 
cattle (Tkalcic et al., 2003; Younts-Dahl et al., 2005; Stephens et al., 2007) without affecting 
feedlot performance of the cattle (Brashears et al., 2003). Lactobacillus strains exert their 
beneficial effect through the production of lactic acid (Ogawa et al., 2001), increase of volatile 
fatty acid concentrations in cattle faeces (Ohya et al., 2000), reduction of biofilm formation of 
E. coli O157:H7 (Kim et al., 2009) and have even been shown to prevent the E. coli O157:H7-
mediated inhibition of IFN-γ-induced transduction signals in epithelial cells (Jandu et al., 2009). 
4.4. Bacteriophages 
Bacteriophages are viruses that infect bacteria, inject their DNA and make use of the 
biosynthetic machinery of the bacterial host to produce daughter phages, which are released via 
host lysis in order to repeat the process in other target bacteria (Callaway et al., 2008). 
Bacteriophages specific for E. coli O157:H7 have been isolated from the faeces of cattle and 
sheep and were able to eliminate E. coli O157:H7 in vitro (Kudva et al., 1999). Bacteriophages 
have also shown their merit in the removal of E. coli O157:H7 contamination from various hard 
surfaces, fruits, vegetables and ground beef, with up to 100% reduction (Abuladze et al., 2008). 
However, in vivo studies demonstrate variable results in ruminants (Table 2). Two separate 
studies with O157-specific phages given orally in single or multiple doses showed that the 
phages were ineffective in reducing E. coli O157:H7 excretion in sheep (Bach et al., 2003; Sheng 
et al., 2006a), whereas application of another phage on the recto-anal mucosa of steers resulted 
in significantly lower levels of E. coli O157:H7 excretion during 10 days post treatment as 
compared to the control group (Sheng et al., 2006a). In contrast, the inhibitory effect of a phage 
cocktail was transient and was not effective at the RAJ.  It has been proposed that phage 
cocktails might be more effective, but a mixture of four phages did not lead to significant 
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differences in reduction of E. coli O157:H7 excretion between control and treatment groups of 
cattle (Rozema et al., 2009). Results from two independent trials where phages were 
administered 2-3 days after experimental challenge with E. coli O157:H7, indicated that numbers 
of E. coli O157:H7 in faeces and/or intestinal contents of sheep were significantly reduced (1,5 to 
3 log10 reduction) but suggest that the inhibitory effect is transient and may not have been 
effective at the RAJ, the preferred colonization site in cattle (Raya et al., 2006; Callaway et al., 
2008). Although generally regarded as a safe, natural and non-antibiotic method to reduce 
pathogens from the food supply, bacteriophage therapy does not yet suffice to be commercially 
used in ruminants for elimination of E. coli O157:H7. 
To date, bacteriophage therapy has not been tested in a natural infection setting. 
 













Sheep Oral Phage DC22, oral, 2 days 
pi 
27 days No significant 
reduction 
Bach et al., 2003 




2-3 log10 reduction 
in caecal and rectal, 
but not ruminal 
contents 
Raya et al., 2006 
Sheep Oral Phage KH1, oral, 1, 9, 10 
and 11 days pi 
21 days No significant 
reduction 
Sheng et al., 
2006a 
Steers Rectal 2-phage-mix, rectal, 7, 8, 
9 and 11 days pi + daily 
addition of phages in 
drinking water 
10 days 1.3-1.5 log10 
reduction from day 
1 to day 10 
Sheng et al., 
2006a 
Sheep Oral 8-phage-mix, oral, 2 and 
3 days pi 
4 days 
(slaughter) 
1.5 – 2 log10 
reduction 
Callaway et al., 
2008 
Steers Oral 4-phage-mix, oral 83 days No significant 
reduction 
Rozema et al., 
2009 
Steers Oral 4-phage-mix, rectal 83 days No significant 
reduction 
Rozema et al., 
2009 
Steers Oral 4-phage-mix, oral and 
rectal 
83 days No significant 
reduction 
Rozema et al., 
2009 




Several research groups have attempted vaccination of cattle as a means to control 
intestinal colonization, with variable results (Table 3). A vaccine based on type III secreted 
proteins (TTSS) reduced E. coli O157:H7 prevalence in feedlot cattle, colonization at the terminal 
rectum and hide contamination, and induced herd immunity (Smith et al., 2008; Moxley et al., 
2009; Smith et al., 2009a; Smith et al., 2009b). Econiche™ (developed by Bioniche Life Sciences 
Inc., Belleville, Ontario, Canada) received full licensing approval from the Canadian Food 
Inspection Agency in October 2008, holds a conditional license for the U.S. market, and is 
thereby the first commercially available E. coli O157:H7 vaccine for use in cattle. However, this 
vaccine is not capable of completely clearing the infection in cattle even after three vaccine 
doses. A completely different strategy targets the bacterial need for iron as nutrient. A 
siderophore receptor and porin-protein (SRP) based vaccine formulation disrupts the iron 
transport system, causing bacterial cell death, and effectively reduced the prevalence of E. coli 
O157:H7 in two cattle feedlot settings (Fox et al., 2009; Thomson et al., 2009). This vaccine 
received a conditional license for the U.S. market in 2009 (Epitopix LLC, Willmar, Minnesota, 
U.S). A conditional license indicates that additional experiments have to be performed to 
demonstrate the efficacy of the vaccine. 
All the above mentioned methods are promising in reducing E. coli O157 prevalence, but 
it is unclear to what extent preharvest burden needs to be reduced to effectively prevent 
contamination of consumable products. The infectious dose to colonize a ruminant has been 
estimated to be lower than 300 CFU (Besser et al., 2001), indicating that levels should be 
drastically reduced to curtail transmission between animals. Interventions should be applied on 
different levels, i.e. on the farm, in the slaughterhouse, in the processing plants, and last but not 
least, the consumer should take minimal precautions. Only with a multi-level strategy can 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5. Virulence factors and pathogenic features of EHEC 
5.1. Shiga toxin 
Shiga toxins are the major virulence determinants of STEC strains. There are two types: 
Stx1, which is almost identical to the Shiga toxin of Shigella dysenteriae type 1, and Stx2, which 
shares 56% amino acid identity with Stx1 (Strockbine et al., 1986). Each type has different 
antigenic variants, which differ in their biological activity and association with disease. Variants 
of Stx1 are thought to be genetic variants without major consequences on the cell toxicity, 
whereas the Stx2 family is more diverse and represents different biological variants (Mainil and 
Daube, 2005). The most commonly described variants are presented in Table 4.  
The nomenclature is sometimes confusing, making it difficult to distinguish the variants 
(Scheutz et al., 2001; Mainil and Daube, 2005; Persson et al., 2007). STEC strains can possess one 
or more variants of Stx1, Stx2 or both. Epidemiological studies have shown that Stx2 is 
associated with more severe human disease. 
 
Table 4: Different types of Shiga toxins 
Stx type Characteristics Reference 
Stx1 Shiga toxin produced by STEC and almost identical to Stx 
produced by Shigella dysenteriae serotype 1 
Strockbine et al., 1986 
Stx1c Variant of Stx1 that is found in ovine and caprine strains but 
not in bovine strains and in some eae-negative STEC; 
associated with mild diarrhoea or no symptoms 
Zhang et al., 2002; Brett et 
al., 2003 
Stx1d A variant from Stx1 isolated from bovine and human strains; 
associated with asymptomatic infections. 
Burk et al., 2003 
Stx2 Prototype of non-Stx1 toxins; associated with severe disease in 
humans 
Strockbine et al., 1986 
Stx2c Associated with diarrhoea and HUS in humans; common in 
bovine and ovine STEC 
Schmitt et al., 1991; Friedrich 
et al., 2002 
Stx2d Associated with eae-negative STEC and mild disease in humans Pierard et al., 1998; Friedrich 
et al., 2002 
Stx2dact Vero cell cytotoxicity is increased 10- to 1000-fold by elastase 
in intestinal mucus; strains with this toxin are highly virulent 
Kokai-Kun et al., 2000 
Stx2e A variant responsible for oedema disease of pigs; rare in 
human disease and associated with mild diarrhoea or 
asymptomatic infections in humans 
Gyles et al., 1988; Sonntag et 
al., 2005a 
Stx2f A variant frequently isolated from pigeon droppings; rare in 
human disease 
Sonntag et al., 2005b 
Stx2g A variant isolated from bovine strains; to date not associated 
with human disease 
Leung et al., 2003 
Adapted from Gyles (2007). 
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The stx genes are located in the genome of lambdoid prophages and are expressed when 
the lytic cycle of the phages is activated (Herold et al., 2004). This activation is linked to 
induction of the bacterial SOS response, that occurs upon DNA damage. When certain antibiotics 
are administered, the SOS response is activated and more Stx are produced and released, 
leading to aggravated disease (Kimmitt et al., 2000).  
The Shiga toxins are part of the AB5 family of toxins, with an A-subunit responsible for the 
enzymatic activity, and a pentameric ring of B-subunits that bind to the cellular receptor. Stx 
bind to Gb3 receptors on epithelial and endothelial cells (Jacewicz et al., 1986; Lingwood, 1993). 
The Stx2e variant binds preferentially to globotetraosylceramide (Gb4) but can also bind Gb3 
(DeGrandis et al., 1989). After binding to the receptor, Stx are internalized by clathrin-mediated 
endocytosis and retrogradely transported to the Golgi apparatus and the endoplasmatic 
reticulum (Sandvig et al., 1992). In the cytosol, the A-subunit is proteolytically cleaved into an 
A1- and an A2-fragment. The A2-fragment remains attached to the B-subunit pentamer, and the 
A1 is now catalytically active (Lea et al., 1999). It specifically removes an adenine residue from 
the 28S rRNA component of eukaryotic ribosomes, leading to inhibition of protein synthesis in 
the cell. Certain cell types go into apoptosis as a result of ribocytotoxic stress response (Smith et 
al., 2003) or due to signalling by Stx (Cherla et al., 2003). 
The absence of disease in cattle is explained by the lack of vascular receptors for Stx 
(Pruimboom-Brees et al., 2000). However, receptors are present on cortical kidney cells and 
crypt epithelial cells of the small and large intestine (Pruimboom-Brees et al., 2000; Hoey et al., 
2002). By targeting crypt cells Stx may affect epithelial development. Indeed, reduced epithelial 
shedding prolonged colonization in ruminants (Magnuson et al., 2000). Stx also bind to 
submucosal lymphoid cells suggesting a role for Stx in immunomodulation (Hoey et al., 2002). 
Receptor-positive cells were not all equally susceptible to Stx-mediated toxicity, owing to the 
presence of different isoforms of Gb3 with differential sensitivities to Stx. In bovine primary 
colonic epithelial cells, Stx is transported into lysosomes instead of to the cytosol, leading to 
degradation of Stx (Hoey et al., 2003). Recently, it has been reported that epithelial and 
mesenchymal cells in the bovine colonic mucosa differ in their responsiveness to Stx1 (Stamm et 
al., 2008). Bovine epithelial cells resisted the cytolethal effect of Stx1 and did not respond to the 
toxin by releasing immune mediators. Mucosal macrophages carry Stx-receptors and alter their 
chemokine and cytokine expression patterns in response to Stx-stimulation. 
Literature review 
29 
5.2. Colonization mechanism of E. coli O157:H7 
EPEC and EHEC have to adhere to intestinal cells to be pathogenic. Binding to host 
intestinal epithelial cells leads to a typical A/E lesion, characterized by a loss of microvilli, 
intimate bacterial attachment to the host cell and actin condensation underneath adherent 
bacteria. To generate this lesion, A/E bacteria use a conserved type III secretion system (TTSS), a 
complex structure at the cell surface resembling a molecular syringe. The LEE encodes the 
structural components of the TTSS, translocated and effector proteins, as well as several gene 
regulators and chaperones. 
Colonization by EPEC and EHEC is a three-step-process: i) initial adhesion, ii) signal 
transduction and cytoskeletal rearrangements and iii) intimate adhesion and pedestal formation 
(Donnenberg et al., 1997) (Figure 2). Several molecules have been implicated in the initial 
binding step, such as OmpA (Torres and Kaper, 2003) and long polar fimbriae (Torres et al., 
2002). However, their exact role remains unclear. It is certain that initial binding of EHEC to host 
cells is dependent on EspA-filaments (Ebel et al., 1998), extending from the bacterial surface to 
make contact with host cells (Knutton et al., 1998). EspB and EspD form a pore in the host cell 
membrane, allowing the translocation of effector molecules through the hollow needle-like 
structure formed by EspA-molecules (Kresse et al., 1999; Daniell et al., 2001). The translocated 
intimin receptor (Tir) is inserted into the host cell membrane, and interacts with the bacterial 
outer membrane protein intimin, thereby establishing an intimate adhesion with the host cell 
(DeVinney et al., 1999). Intimin is also known to bind the host cell receptors β1 integrins and 
nucleolin (Frankel et al., 1996; Sinclair and O'Brien, 2002) but the role of these interactions in 
vivo is not clear. Upon intimate adhesion, bacteria multiply and develop microcolonies on the 
epithelial cell surface (Tatsuno et al., 2000). 
Tir adopts a hairpin-like structure in the host cell membrane, where the extracellular 
domain interacts with intimin, and the N- and C-termini are located in the cytosol, interacting 
with host cell proteins. In contrast to EPEC Tir (Rosenshine et al., 1996), EHEC Tir does not have 
to be phosphorylated to initiate the cascade of events leading to the formation of an A/E lesion 
(DeVinney et al., 1999). Instead, Tir is linked indirectly to the actin cytoskeleton by the Tir-
cytoskeleton coupling protein TccP (also named EspFU) (Garmendia et al., 2004), via a host 
protein, the insulin receptor tyrosine kinase substrate (IRTKS), a homologue of the insulin 
receptor substrate protein of 53 kDa (IRSp53) (Vingadassalom et al., 2009; Weiss et al., 2009). 
IRSp53 family members are key regulators of membrane and actin dynamics. TccP interacts with 
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the neural Wiskott Aldrich syndrome protein (N-WASP) to activate the Arp2/3 complex which 
mediates actin nucleation. Actin condensation underneath adherent bacteria leads to the 
formation of a pedestal, on which the bacteria rest (Knutton et al., 1989). Following attachment 
and effector translocation, expression of the EspA needle complex and intimin is downregulated 
(Knutton et al., 1997; Knutton et al., 1998; Dahan et al., 2004). 
It is clear from this cascade of events that EHEC has evolved an ingenious strategy to 
attach itself to the host cell, inserting not only its own receptor and a linker molecule but also 
usurping host regulators of cytoskeleton dynamics. It can be speculated that such a tight 
interaction between bacterium and host cell will impair the removal of EHEC by immune cells. 
Furthermore, EHEC has developed several strategies to evade the host immune system, which 





Figure 2: Model of translocation of bacterial effectors into host cells. (a) Upon establishment of initial contact by a 
mostly unknown mechanism, EPEC and EHEC use a type III translocation apparatus to inject bacterial effector 
proteins into mammalian cells. These bacteria translocate a number of proteins: EspB and EspD, which form a 
translocon in the plasma membrane; the cytoplasmic proteins EspF, EspG and Map (there is also a cytoplasmic pool 
of EspB); the translocated intimin receptor Tir, which inserts into the plasma membrane; and other effectors. (b) 
Membrane-localized Tir contains a central extracellular domain that binds to the bacterial outer membrane protein 
intimin, and amino- and carboxy-terminal cytoplasmic domains that interact with cytoskeletal elements. The 
interaction between Tir and intimin is the final bacterial signal to trigger the assembly of actin into pedestals within 
host cells. Adapted from Campellone and Leong (2003). 
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5.3. Plasmid pO157 
All EHEC strains possess a large plasmid of 90 kb or 60MDa, the pO157 plasmid. Plasmids 
of different E. coli O157:H7 strains are highly conserved, differing only at the single nucleotide 
polymorphism level (Zhang et al., 2006). The complete sequence of the pO157 plasmid was 
determined, revealing several putative virulence factors (Burland et al., 1998; Makino et al., 
1998). An overview of the most prominent virulence factors encoded on the pO157 is given 
here. 
Enterohaemolysin or EHEC-haemolysin is related to alpha-haemolysin but is not identical 
(Schmidt et al., 1995). The hlyCABD operon contains four genes, encoding a pore-forming 
cytolysin and its secretion apparatus. Toxicity results from the insertion of enterohaemolysin 
into the cytoplasmic membrane of the target mammalian cells disrupting permeability control. 
How enterohaemolysin contributes to the pathogenesis is not well understood. It is possible that 
the haemoglobin released by the action of the haemolysin provides a source of iron, thereby 
stimulating the growth of EHEC bacteria in the intestine (Law and Kelly, 1995). In addition to 
lysing erythrocytes, the toxin lyses bovine but not human lymphocytes (Bauer and Welch, 1996). 
Enterohaemolysin is expressed during in vivo infection since it was found to reac with sera from 
HUS patients (Schmidt et al., 1995) and bovine colostra (Lissner et al., 1996). 
KatP is a catalase-peroxidase encoded on the O157 plasmid, which protects EHEC from 
oxidative stress (Brunder et al., 1996; Uhlich, 2009). The occurrence of the katP gene in EHEC 
strains is associated with the hly operon (Brunder et al., 1997). 
EspP is a secreted serine protease that cleaves pepsin A and human coagulation factor V 
(Brunder et al., 1997). EspP contributes to adherence of E. coli O157:H7 to primary bovine rectal 
cells and to colonization in vivo as an espP deletion mutant was excreted in lower numbers by 
calves than the parent strain (Dziva et al., 2007a). 
StcE or secreted protease of C1 esterase inhibitor (C1-INH) is a metalloprotease that 
specifically cleaves C1-INH, a host regulator of multiple proteolytic cascades, including the 
classical and alternative complement pathway, coagulation and contact activation pathways 
(Caliezi et al., 2000, Jiang et al., 2001). Resulting pathology from E. coli O157:H7 infections may 
include localised proinflammatory and coagulation responses, causing tissue damage, intestinal 
oedema and thrombotic abnormalities (Lathem et al., 2002). StcE is thought to promote 
adherence through destruction of proteins in the glycocalyx thereby allowing O157:H7 to come 
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into close contact with the intestinal mucosa (Grys et al., 2005) and to aid E. coli O157:H7 in 
resisting the complement pathway of the innate immune response (Lathem et al., 2004). 
Lymphostatin/Efa-1/ToxB are homologous proteins in respectively EPEC, non-O157 EHEC 
and E. coli O157:H7. Lymphostatin inhibits lymphocyte proliferation of human peripheral blood 
lymphocytes (PBMC) and the mitogen-activated synthesis of proinflammatory cytokines 
(Klapproth et al., 1995; Klapproth et al., 2000), as well as human and murine intestinal 
lymphocytes (Klapproth et al., 1996; Malstrom and James, 1998) but has no effect on the 
formation of A/E lesions. The efa-1 gene (EHEC factor for adherence) is 99.9% identical in 
nucleotide sequence to the EPEC lifA, mediates bacterial adherence to cultured epithelial cells 
on its own and influences intestinal colonization of calves by non-O157 EHEC strains (Nicholls et 
al., 2000; Stevens et al., 2002b). E. coli O157:H7 strains encode a truncated efa-1’ gene, that 
influences bacterial adhesion, but also contain a functional homologue protein to lymphostatin, 
namely toxB (Klapproth et al., 2000). The ToxB protein shares a considerable homology (28% of 
identical amino acids and 47% of similar amino acids) with the product of efa-1/lifA (Morabito et 
al., 2003). Tatsuno and colleagues showed that the product of the toxB gene contributes to the 
adherence of EHEC O157 to Caco-2 cells through the promotion of the production and/or the 
secretion of type III secreted proteins (Tatsuno et al., 2001). A plasmid-cured E. coli O157 strain 
could still adhere to Caco-2 cells, but developed fewer microcolonies than the parent strain. 
Furthermore, the plasmid-cured strain could not inhibit IL-2 and IL-4 synthesis in mitogen-
activated PBMC (Klapproth et al., 2000). However, it is unclear whether this effect can be solely 
attributed to ToxB as other cytotoxins encoded on the plasmid such as enterohaemolysin or StcE 
may also be responsible. In contrast to non-O157 strains, mutation of E. coli O157 ToxB did not 
affect intestinal colonization of calves and sheep (Stevens et al., 2004).  
Lymphostatin has recently been shown to contribute to pathogenesis of C. rodentium by 
disrupting the intestinal barrier via the modulation of Rho GTPases (Babbin et al., 2009). It is  
unclear how one protein can exhibit such different functions as a role in adhesion and 
modulation of the host immune response. Together, these data indicate that lymphostatin and 
its homologues are important virulence factors in A/E bacteria. 
Karch et al. (1987) first reported that the O157 plasmid is associated with the expression 
of fimbriae that enhance bacterial adherence to epithelial cells. However, other studies have 
shown that the plasmid has no effect on adhesion or that it resulted in reduced or even 
increased adherence (Tzipori et al., 1987; Toth et al., 1990; Fratamico et al., 1993; Nataro and 
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Kaper, 1998). These conflicting results may be explained by the use of animal models such as 
mice, gnotobiotic piglets and rabbits which do not correlate well with human disease caused by 
E. coli O157:H7. It has recently been reported that pO157 influences colonization of the bovine 
terminal rectum. Strains missing the plasmid were cleared faster than the wild type strain, 
showing its requirement for long-term colonization in cattle (Sheng et al., 2006b; Lim et al., 
2007b). Enterohaemolysin deletion mutants did not influence persistence (Lim et al., 2007b). 
5.4. Effector molecules 
Although EHEC remains extracellular, it has extensive intracellular effects. Host cell 
signalling pathways are subverted and manipulated, resulting in efficient colonization and 
evasion of host immune responses. These effects are the result of the coordinated action of a 
large repertoire of effector molecules that are injected into the cell by the TTSS (Figure 3). Many 
of these translocator effectors have multiple or redundant functions. The first effectors that 
were discovered were all encoded on the LEE, but more recently, effectors encoded outside the 
LEE have been found in all A/E pathogens. These non-LEE effector molecules are carried on 
prophages or other pathogenicity islands. The role of the effector proteins has mostly been 
investigated in EPEC. 
In 2009, 21 LEE and non-LEE effectors were known in EPEC E2348/69, the prototype 
strain used worldwide to study EPEC infection (Iguchi et al., 2009). The EHEC O157 Sakai strain 
encodes 49 potentially functional effectors, representing the most complex repertoire among 
A/E pathogens (Tobe et al., 2006). The roles of other recently identified effectors such as EspK, 
EspM and EspT have not yet been clearly defined (Tobe et al., 2006; Vlisidou et al., 2006b; 
Arbeloa et al., 2009; Bulgin et al., 2009). The most important findings regarding effector 





5.4.1. LEE-encoded effectors 
Mitochondrion-associated protein (Map) was the second effector protein that was 
identified after Tir. Map displays three distinct and independent functions: (i) in initial stages of 
EPEC/EHEC infection, Map is responsible for the transient formation of filopodia at the site of 
bacterial infection, a process that is dependent on the small regulatory GTPase protein Cdc42, 
which normally directs filopodia formation within host cells (Kenny et al., 2002); (ii) it interferes 
with the cellular ability to maintain mitochondrial membrane potential, triggering the formation 
of misshapen mitochondria, mitochondrial swelling and damage (Kenny and Jepson, 2000); and 
(iii) it is essential for the disruption of intestinal barrier function and alteration of tight junctions, 
and this activity is independent of the mitochondrial targeting (Dean and Kenny, 2004). 
Interestingly, Map signalling is inhibitory to Tir-intimin-triggered pedestal formation (Kenny et 
al., 2002). 
 
Figure 3: EPEC and EHEC translocate LEE-encoded and other effector proteins into the host cell cytosol. These 
effectors trigger cytoskeleton rearrangements (Tir, EspH, EspF, and EspG), disruption of the epithelial barrier (EspF 
and Map), cytotoxicity (EspF and Cif), and host cell responses that ultimately generate watery diarrhoea. Different 
from EPEC Tir, EHEC Tir is not tyrosine phosphorylated and does not interact with Nck in order to trigger actin 
polymerization at the site of bacterial adhesion; instead, EHEC translocates an effector protein, TccP/EspFu, which 
has an Nck-like activity and is essential to promote the reorganization of the actin cytoskeleton underneath 
adherent EHEC bacteria. ER, endoplasmic reticulum. (Garmendia et al., 2005). 
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EspB forms a pore in the host cell membrane, through which effector proteins are 
translocated. In addition, it is translocated itself to the cytosol near the site of bacterial 
attachment (Taylor et al., 1998) and is thought to have an effector function with a role in 
cytoskeleton modulation. Cells transfected with EPEC EspB display altered morphology with a 
reduced number of stress fibres (Taylor et al., 1999). Kodama and co-workers identified the 
cytoskeleton-associated protein α-catenin as the direct binding partner of E. coli O157:H7 EspB, 
but its role in actin accumulation and A/E lesion formation is unclear (Kodama et al., 2002). EPEC 
is known to inhibit phagocytosis (Goosney et al., 1999), mediated by EspB as shown recently 
(Iizumi et al., 2007). When injected into the host cell, EspB inhibits the interaction between actin 
and myosins, a superfamily of proteins that interact with actin filaments and mediate essential 
cellular processes, including microvillus formation and phagocytosis (Iizumi et al., 2007). 
EspF from EPEC plays a central role in decreasing transepithelial electrical resistance 
(TER) and in altering the intestinal epithelial tight junction structure in vitro (McNamara et al., 
2001). The ability of EspF to alter the TER, but not the delivery into host cells, was found to be 
dependent on expression of intimin, showing that EPEC can control the activity of effector 
molecules independent of Tir (Dean and Kenny, 2004). Although originally EspF was thought not 
to be involved in A/E lesion formation, it has been shown recently that EspF has an affinity for 
profilin, Arp2/3 and actin (Peralta-Ramirez et al., 2008). Furthermore, EPEC EspF can inhibit 
phagocytosis (Quitard et al., 2006) and it was shown that EspF disrupts nucleolin by a process 
regulated by mitochondrial dysfunction, possibly targeting the cell’s energy resources (Dean et 
al., 2010). 
However, there are marked differences between EPEC and EHEC. EHEC-induced 
reduction in TER is significantly slower and more modest in comparison with that induced by 
EPEC (Viswanathan et al., 2004). Furthermore, deletion of the espF gene promoted the 
accumulation of polymorphonuclear cells in the rabbit intestinal mucosa, which suggests that 
EspF may be important to dampen the host inflammatory response to EHEC (Ritchie and Waldor, 
2005). 
EspG and its homologue EspG2 bind to tubulins and cause localized microtubule 
depolymerisation, resulting in actin stress fibre formation (Matsuzawa et al., 2004; Hardwidge et 
al., 2005). They are implicated in the diarrhoeal progress of disease caused by C. rodentium 
infections, by partially altering the location of aquaporin water channels (Guttman et al., 2007). 
Nevertheless, an espG mutant strain displayed only slight attenuation in animals in the rabbit 
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EPEC infection model and the C. rodentium mouse model (Elliott et al., 2001; Deng et al., 2004; 
Mundy et al., 2004). However, in a rabbit EHEC infection model, an espG deletion mutant formed 
A/E lesions in the colon but ileal colonisation was reduced approximately 10-fold in comparison 
with the wild type strain (Ritchie and Waldor, 2005). 
EspH is a modulator of the host cytoskeleton, by down-regulating filopodium formation 
and promoting pedestal formation in HeLa cells infected with EPEC or EHEC (Tu et al., 2003). It is 
thought to promote EHEC colonization in the rabbit intestinal tract (Ritchie and Waldor, 2005).  
SepZ (also named EspZ) is hypervariable among A/E pathogens, with sequences sharing 
between 60 and 81% amino acid identity between EHEC and EPEC SepZ (Kanack et al., 2005). 
Interestingly, the allele subtype of the espZ gene correlates with the intimin subtype among 
EHEC strains (Gilmour et al., 2006). A specific 8 to 10 amino acid loop between 2 predicted 
transmembrane domains is the most hypervariable part of the protein, suggesting that it may 
represent a region that interacts directly with host proteins (Kanack et al., 2005). Although it is 
known that SepZ is translocated early in the infection process and at similar levels as the 
important effector Tir (Mills et al., 2008), a role in pathogenesis of A/E pathogens has not yet 
been defined (Deng et al., 2004; Kanack et al., 2005). Recently, it has shown that EspZ/SepZ 
interacts with CD98 and protects the host cell against EPEC-mediated cytotoxicity (Shames et al., 
2010). 
5.4.2. Non-LEE effectors 
Cycle inhibiting factor (Cif) of EPEC and EHEC strains triggers an irreversible cytopathic 
effect in epithelial cells, characterized by progressive recruitment of focal adhesions, assembly of 
stress fibres and the arrest of the cell proliferation in G1 and G2 phases (Marches et al., 2003; 
Samba-Louaka et al., 2008). Cif not only induces cell cycle arrest but eventually provokes delayed 
cell death (Samba-Louaka et al., 2009). Cell cycle inhibitors might impair epithelial-barrier 
integrity allowing the entry of pathogenic bacteria into the body or prolonging their existence by 
blocking the shedding of epithelia (Marches et al., 2003). The latter study suggests that targeting 
of intestinal T-cells by Cif could have serious effects on the innate and adaptive immune 
responses. Unfortunately, this has not been investigated yet, and the role of Cif in EPEC and 
EHEC pathogenesis in vivo remains to be elucidated. Cif was detected in different EHEC 
serotypes but not in E. coli O157:H7 strains (Marches et al., 2003; Loukiadis et al., 2008). 
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Moreover, Loukiadis et al. showed that not all cif-positive strains encode a full-length gene or a 
functional protein. 
EspJ of EPEC and EHEC inhibits opsono-phagocytosis by macrophages, possibly through 
targeting of a host cell molecule normally involved downstream of the phagocytic receptors FcγR 
and CR3 as EspJ inhibits phagocytosis mediated by these receptors (Marches et al., 2008). 
Several non-LEE encoded effectors (Nle), NleA to I, have been described. Most of them 
were originally identified in the genome of C. rodentium and are conserved among A/E 
pathogens (Deng et al., 2004; Garcia-Angulo et al., 2008). The functions of some of these 
proteins have been investigated, mostly in EPEC. NleA is implicated in disrupting intestinal tight 
junctions between epithelial cells by EPEC, and this effect may be mediated by disruption of 
cellular protein trafficking (Kim et al., 2007; Thanabalasuriar et al., 2010). Results from EHEC 
infection of HeLa cells suggest that NleA may contribute to resisting host clearance of infection 
(Gruenheid et al., 2004). NleB and NleE are involved in subverting innate immune responses to 
EPEC, whereby NleE blocks NF-κB p65 nuclear translocation, leading to reduced IL-8 production 
(Newton et al., 2010) and NleB enhances the inhibition of NF-κB by the NleE protein (Nadler et 
al., 2010). NleD was found to play a role in the intestinal colonization of calves using signature-
tagged mutagenesis (Dziva et al., 2004), however this was in contrast with a later study which 
showed that both NleC and NleD were not required for colonization of calves and lambs 
(Marches et al., 2005). NleF plays a role in the colonization of gnotobiotic piglets by EHEC 
(Echtenkamp et al., 2008). NleG homologues actually represent a large family of effector 
proteins found in pathogenic E. coli, with fourteen members in E. coli O157:H7 alone. NleG 
proteins exhibit a strong autoubiquitination activity in vitro but their role in vivo has not been 
investigated yet (Wu et al., 2010). NleH was shown to cause an increase in NF-κB activity and 
TNF-α expression in the mouse colonic mucosa (Hemrajani et al., 2008), and modulates 
apoptotic responses during EPEC and C. rodentium infections by inhibiting caspase activation 
(Hemrajani et al., 2010). In EHEC, NleH binds to the human ribosomal protein S3, which is a 
subunit of NF-κB, and thereby contributes to the disruption of host immune responses (Gao et 
al., 2009). NleI was identified in EPEC and facilitates secretion of other effector molecules, 
including NleA, F and H (Li et al., 2006). 
 
In summary, EPEC and EHEC use multiple proteins with redundant functions to subvert 
host cell functions. EPEC and EHEC are related pathogens and share many virulence 
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characteristics. However, marked differences exist and it would be unwise to attribute functions 
of effectors identified in EPEC without prior investigation to the EHEC effector homologue. 
5.5. Effect of E. coli O157:H7 on the host cell 
From the still growing list of effector molecules and virulence factors, it is clear that E. coli 
O157:H7 exerts many effects on the host cell. Infection with E. coli O157:H7 triggers a complex 
interplay of communication between the bacteria and the host cell. Activated enterocytes 
produce cytokines, which attract leucocytes to the site of infection and induce mucosal 
inflammation. Host cells recognize certain structures on the bacteria, the pathogen-associated 
molecular patterns (PAMPs). Several molecules of E. coli O157:H7 have been implicated in this 
process. OmpA of E. coli O157:H7 induced mouse dendritic cells to secrete IL-1, IL-10, and IL-12 
in a dose-dependent manner, and this effect was enhanced by incubation of the bacteria with 
OmpA-specific antibodies, forming immune complexes (Torres et al., 2006). Stx and H7 flagellin 
are other potent inducers of cytokine secretion (Thorpe et al., 1999; Rogers et al., 2003; 
Miyamoto et al., 2006; Gobert et al., 2008), as well as proteins of the LEE, but intimate adhesion 
is not a prerequisite for secretion of IL-8 and CCL20 (Gobert et al., 2008). An as yet unidentified 
molecule of E. coli O157:H7 inhibits IFN-γ-induced activation of the JAK/STAT pathway upon 
adhesion, and this molecule is not a LEE or TTSS protein, Stx1 or Stx2, and is not encoded on the 
pO157 plasmid (Ceponis et al., 2003; Jandu et al., 2007). Not only IFN-γ-induced signalization is 
impaired, E. coli O157:H7 inhibits IFN-γ secretion from lymphocytes (Klapproth et al., 2000). 
IFN-γ might play an important role during EHEC infection, as suggested by the inability of IFN-γ-
knockout mice to clear C. rodentium infection (Simmons et al., 2002). Furthermore, E. coli 
O157:H7 interferes with NF-κB activation initiated by TNF-α, suppressing IL-1, IL-6 and IL-8 
secretion (Hauf and Chakraborty, 2003). 
The watery diarrhoea seen in the initial stage of human disease is thought to be caused 
by a change in TER, as seen in infected human intestinal T84 cells. E. coli O157:H7 alters the 
distribution of tight junction-associated proteins, thereby influencing the epithelial permeability 
(Philpott et al., 1998). T84 cells have been used to study another aspect of the pathogenesis, 
namely the effect of Stx on human intestinal epithelial cells.  The latter do not express the Stx-
receptor (Schuller et al., 2007), but are able to translocate Stx into the blood stream (Thorpe et 
al., 1999). It was shown that E. coli O157:H7 actually suppresses the inflammatory host response 
to cytokines and Stx, by inhibiting the Stx-induced IL-8 secretion. It seems that E. coli O157:H7 is 
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able to protect the integrity of the epithelium by dampening the host response to its toxin 
(Bellmeyer et al., 2009). 
Immunomodulation by Stx has also been implicated in the ability of E. coli O157:H7  to 
persist in cattle. Stx1 can block the proliferation of bovine lymphocytes in vitro (Menge et al., 
1999). More specifically, bovine CD8+ and CD21+ cells are involved, and to a lesser extent CD4+ 
cells. This effect is not mediated by cytokines but is the result of the direct action of Stx on 
bovine lymphocytes (Menge et al., 2003). Bovine B- and T-lymphocytes, including ileal and 
colonic intraepithelial lymphocytes, express Gb3/CD77 molecules in vitro that function as Stx-
receptors (Menge et al., 2001; Stamm et al., 2002; Menge et al., 2003). In addition, it has been 
shown that another E. coli O157:H7 molecule, lymphostatin, has a similar blocking effect on 
bovine lymphocytes (Abu-Median et al., 2006). 
6. Immune response to E. coli O157:H7  
Humans and animals respond immunologically to E. coli O157:H7 infections. In contrast 
to what has since long been perceived, E. coli O157:H7 is not a commensal of the bovine host, 
but induces inflammation and can be considered as a bovine pathogen. Although cattle do not 
experience clinical symptoms, it has been discovered recently that E. coli O157:H7 induces small 
mucosal haemorrhages and focal petechiae in the intestine of colonized cattle, that remain 
visible several months after ceasing of shedding (Baines et al., 2008). 
6.1. Human response 
Serum antibodies reactive to E. coli O157:H7 lipopolysaccharide (LPS) have been 
repeatedly reported in haemorrhagic colitis and HUS-patients (Bitzan et al., 1991; Flores et al., 
1997; Jenkins and Chart, 1999; Tanaka et al., 2000) and can be used for serodiagnosis of E. coli 
O157:H7 infections that otherwise would be unnoticed due to concurrent infections (Flores et 
al., 1997) or when faecal bacteria cannot be detected. IgM and IgA antibodies to O157 LPS were 
also detected in breast milk of an E. coli O157-infected pregnant woman (Tanaka et al., 2000) 
and in saliva of children with HUS (Ludwig et al., 2002b). However, serum antibodies in HUS-
patients were not long-lasting and disappeared 5 (IgA) or 11 weeks (IgG and IgM) after the onset 
of diarrhoea (Ludwig et al., 2002a). Recurrent E. coli O157:H7 infections with HUS have been 
reported (Siegler et al., 1993), indicating that O157 LPS-specific antibodies may not protect 
against subsequent E. coli O157:H7 infections.  
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Besides LPS, patients react against intimin, EspA, EspB and Tir (Jenkins et al., 2000; Li et 
al., 2000). Titres against these proteins were strongly elevated by day 8 after hospitalisation due 
to E. coli O157:H7 infection, in comparison with titres of acute-phase sera (Li et al., 2000). The 
response decreased by day 60 and was highest against Tir. However, Karpman et al. (2002) 
observed the highest responses against EspB during the acute phase. Reactive antibodies are 
sometimes present in sera from healthy control subjects, indicating the similarity of EHEC 
antigens between different E. coli serotypes (Jenkins et al., 2000; Karpman et al., 2002).  
Serum antibodies to enterohaemolysin and H7 flagella have been detected, but are not 
useful for serodiagnosis of E. coli O157:H7 infections as they were only present in a minority of 
patients (Jenkins and Chart, 1999). On the other hand, patients with HUS did not have serum 
antibodies to either A or B subunits of Stx1 or Stx2 (Chart et al., 1993). 
Studies of cytokine responses focus on HUS-patients. Typically, diarrhoea precedes the 
development of HUS by several days. Westerholt et al. (2000) concluded from a study conducted 
in children with diarrhoea caused by EHEC that high IL-8 and low IL-10 levels are risk factors for 
developing HUS. In contrast, Murata et al. (1998) found increased levels of IL-10 in EHEC-related 
HUS, as well as increased TNF-α, IL-6, IL-8 and granulocyte colony-stimulating factor. The host 
immune response differs between uncomplicated E. coli O157:H7 infection and HUS-
development, and is likely a reflection of inter-person variability rather than a O157-specific 
immune response (Proulx et al., 1998). 
The secreted cytokines attract leucocytes to the site of infection. Histological analysis of 
colonic biopsies of E. coli O157:H7-infected patients showed infiltration of monocytes and 
neutrophils in the crypts and the lamina propria (Griffin et al., 1990; Shigeno et al., 2002). 
6.2. Response in ruminants 
Naturally infected cattle develop serum antibody responses against various E. coli 
O157:H7 antigens such as Stx and LPS (Pirro et al., 1995; Cristancho et al., 2008). Bovine 
colostrum contains antibodies directed against Stx, LPS and E. coli O157:H7 proteins involved in 
adhesion (Lissner et al., 1996; Widiasih et al., 2004b; Vilte et al., 2008), which could explain the 
low prevalence in pre-weaned calves (Garber et al., 1995). 
Whereas anti-Stx1 antibodies were detected in all colostrum and serum samples 
obtained from 24 dams immediately after parturition, they were present only in a minority of 
milk samples and in low amounts. The anti-Stx1 antibodies were transferred to newborn calves 
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via the colostrum, but titres declined by six weeks of age whereafter calves became increasingly 
susceptible to natural E. coli O157:H7 infection (Frohlich et al., 2009). Anti-Stx2 antibodies were 
only rarely detected under natural conditions (Frohlich et al., 2009) or after repeated 
experimental infections (Johnson et al., 1996; Hoffman et al., 2006).  
Although detection of serum antibodies in humans can be used to diagnose E. coli 
O157:H7 infection, the presence of serum antibodies is probably not a useful parameter to 
determine the infection status of ruminants. Seroconversion to active IgM and IgG anti-LPS 
antibody responses in some calves was not associated with isolation of the bacteria (Cristancho 
et al., 2008), indicating possible cross-reactivity to LPS of non-O157 strains or other bacterial 
species. However, limited cross-reactivity to TTSS proteins of O157 and non-O157 strains was 
reported (Asper et al., 2007). Recently it has been discovered that the subtilase cytotoxin of 
E. coli O157:H7 blocks secretion of newly synthesized antibodies in vitro, but this effect remains 
to be investigated in vivo during the course of E. coli O157:H7 infection (Hu et al., 2009). 
Antibodies to a greater variety of E. coli O157:H7 antigens have been shown in 
experimentally infected cattle, including Stx-, LPS-, and TTSS protein-specific antibodies. These 
antibodies inhibit E. coli O157:H7 adhesion to cells in vitro (Paton et al., 1998), but pre-existing 
antibody titres do not prevent colonization of cattle following experimental inoculation 
(Bretschneider et al., 2007b). However, it has been speculated that acquired immunity may 
account for reduced shedding after repeated inoculations (Johnson et al., 1996; Sanderson et al., 
1999; Naylor et al., 2007). Still, the immune response during the course of an E. coli O157:H7 
remains largely unknown. 
Mucosal responses following experimental infection of cattle include infiltration of 
granulocytes in the lamina propria of the terminal rectum, and rectal IgA antibodies recognizing 
several O157 antigens (Bretschneider et al., 2008; Nart et al., 2008a; Nart et al., 2008b). Faecal 
IgG and IgA antibodies were not detected (Bretschneider et al., 2007b). 
Results from in vitro studies have generated the hypothesis that E. coli O157:H7 can 
actively suppress the host immune response (Menge et al., 1999), and this was supported by the 
reduced cellular responses of cattle experimentally infected with an Stx2-positive strain 
compared to those infected with an Stx2-negative strain (Hoffman et al., 2006). 
Anti-H7 flagellin antibodies purified from immunized calves, were capable of partially 
blocking adhesion of E. coli O157:H7 to primary rectal epithelial cells (McNeilly et al., 2008). 
Interestingly, these IgG and IgA antibodies recognised different epitopes and the IgG antibodies 
Literature review 
42 
interfered with Toll-like receptor (TLR) 5 signalling (McNeilly et al., 2010). Inhibition of TLR 
signalling may reduce vaccine efficacy by interfering with innate responses to the bacterium, and 
may explain that although less animals became colonized after vaccination, animals that were 
colonized sustained bacterial peak levels for longer periods than did the unvaccinated controls 
(McNeilly et al., 2008). Rectal immunisation induced rectal IgA, which had no effect on bacterial 
shedding, in contrast to IgG induced by systemic immunization that reduced shedding and 
delayed the peak of shedding (McNeilly et al., 2008). 
 
Immune responses of sheep against E. coli O157:H7 have not been studied before and 
are investigated in this thesis. 
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Aims of the study 
Whereas many investigations have focused on the colonization mechanisms of E. coli 
O157:H7, the nature of the immune response against this pathogen has received only limited 
attention. It has been hypothesized that infection with E. coli O157:H7 can persist in ruminants 
due to suppression of the host immune system. While it is known that cattle develop antibodies 
after natural and experimental infection with E. coli O157:H7, the immune response of sheep 
against E. coli O157:H7 has not been studied before. 
 
The general aim of this thesis was to gain insight in the interaction of E. coli O157:H7 with 
the immune system of sheep. 
 
The following questions were addressed: 
 
Does experimental infection of sheep with E. coli O157:H7 lead to persistent colonization? 
 By a rectal inoculation route? (Chapter 1) 
 By an oral inoculation route? (Chapter 2) 
 Where is the infection localized? (Chapter 1 & 2) 
Does infection result in an immune response that protects against re-infection? 
 What is the systemic immune response? (Chapter 1, 2 & 3) 
 What is the local immune response? (Chapter 1, 2 & 3) 
What is the role of the immune response in clearance of E. coli O157:H7 infection?  
 What is the influence of preceding immunisation? (Chapter 3) 
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Rectal inoculation of sheep with E. coli O157:H7 results in 
persistent infection in the absence of a protective immune 
response 
Based on: Vande Walle K., Atef Yekta M., Verdonck F., De Zutter L., Cox E., 2010. Rectal inoculation of 
sheep with E. coli O157:H7 results in persistent infection in the absence of a protective immune response. 
Veterinary Microbiology, in press, doi: 10.1016/j.vetmic.2010.06.033.  
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1.1. Abstract 
Escherichia coli (E. coli) O157:H7 can cause haemorrhagic colitis and the haemolytic 
uremic syndrome in humans. Ruminants are the main reservoir for this bacterium: they can 
harbour the bacteria in the gastro-intestinal tract without showing clinical symptoms. The reason 
for this persistence is still unclear, although it has been suggested that E. coli O157:H7 can 
suppress the immune system. To investigate the effects on the immune system of ruminants, an 
infection model is needed that mimics a long-term infection as it can occur in both sheep and 
cattle. As the terminal rectum has recently been identified as a primary colonization site in 
cattle, we developed a rectal inoculation model for sheep and used this model to study immune 
responses against selected virulence factors of E. coli O157:H7 (intimin, EspA and EspB). Sheep 
were infected and re-infected when E. coli O157:H7 excretion was no longer detectable. The 
animals did not develop serum or local antibody responses but showed a cellular response 
against EspA and intimin respectively 9 en 16 days after infection. This response was also present 
5 days after re-infection, albeit lower, and did not prevent animals from being re-infected. These 
results demonstrate that E. coli O157:H7 can be persistently present in the large intestine of 
sheep without inducing a clear protective immune response. 
1.2. Introduction 
Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 is associated with haemorrhagic 
colitis and the haemolytic uremic syndrome in humans (Paton and Paton, 1998), with food and 
drinking water contaminated with animal faeces being the most important sources of infection 
for humans (Hancock et al., 2001). Ruminants transiently harbour E. coli O157:H7 in their 
gastrointestinal tract, and more specifically the terminal rectum has been identified as a primary 
colonization site of E. coli O157:H7 in cattle (Naylor et al., 2003). Given the reported variation in 
duration of faecal excretion after oral inoculation (Brown et al., 1997; Cookson et al., 2002; 
Grauke et al., 2002; Sheng et al., 2004) and the need for an experimental model mimicking a 
more long-term infection in cattle, Sheng and co-workers (2004) used rectal swab inoculation to 
target the primary colonisation site of E. coli O157:H7. This resulted in consistent long-term 
colonization of adult steers, with excretion lasting more than one month post inoculation. 
Cattle develop serum antibodies against virulence factors of E. coli O157:H7 (such as 
intimin, EspA, EspB, Tir, LPS and Shiga toxin) after natural and experimental infection (Pirro et al., 
1995; Johnson et al., 1996; Hoffman et al., 2006; Bretschneider et al., 2007b), but the role of the 
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immune system in persistence of E. coli O157:H7 is poorly understood. It has been suggested 
that protective immune responses occur, based on reduced shedding following immunization 
with type III secreted proteins (Potter et al., 2004; Smith et al., 2009b) and after repeated 
experimental infections (Sanderson et al., 1999; Naylor et al., 2007). A better knowledge of the 
immune response that occurs during infection may lead to improved understanding of the 
mechanisms behind persistence and clearance of the infection. This knowledge might be crucial 
to create effective control measures of EHEC colonization in ruminants, thereby reducing the 
spread to humans. 
Most studies focus on cattle, but sheep are an established ruminant model for E. coli 
O157:H7 colonization after oral inoculation (Wales et al., 2001a; Wales et al., 2001b; Cookson et 
al., 2002; Woodward et al., 2003; Best et al., 2009). In the present study, rectal inoculation of 
sheep was used to develop a persistent infection model, and to study the immune response to 
virulence factors of E. coli O157:H7.  
1.3. Material and methods 
1.3.1. Bacterial inoculums 
NCTC12900 is a well characterized Shiga toxin-negative E. coli O157:H7 strain with 
spontaneous nalidixic acid resistance (Dibb-Fuller et al., 2001; Wales et al., 2002; Woodward et 
al., 2003). For preparation of bacterial inocula, NCTC12900 was grown overnight in Luria Bertani 
broth at 37°C while shaking (200 rpm), washed and resuspended in PBS to the desired 
concentration as described below. 
1.3.2. Experimental animals 
Conventionally reared sheep (Belgian cross-breed, Zootechnical Centre, Leuven, Belgium) 
were screened at the age of ten weeks, to verify the absence of E. coli O157:H7 in faeces and 
serum antibodies against intimin, EspA and EspB. Selected animals were allowed to acclimatize 
for one week after arrival in our facilities. Sheep were housed in groups of two to five animals 
per pen and received a complete pelleted diet and water ad libitum. All experimental and animal 
management procedures were approved by the Animal Care and Ethics Committee of the 
Faculty of Veterinary Medicine, Ghent University. 
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1.3.3. Experimental procedures 
Experiment 1 
A first experiment was performed to test different rectal inoculation methods. Twelve 
lambs were divided into 5 groups: groups 1 (n=3) and 2 (n=3) were administered a liquid 
inoculum into the rectal cavity by means of a syringe and a flexible plastic tube, in a low (107 
CFU, group 1) or high dose (1010 CFU, group 2) in a total volume of 20 ml. Groups 3 (n=2) and 4 
(n=2) received 1010 CFU in 2 ml absorbed in a surgical sponge (Spongostan® Standard) on 1 
(group 3) or 2 consecutive days (group 4). Inoculation with a sponge is hereafter referred to as 
the 1-day-sponge or 2-days-sponge method. Previously, it was determined that at least 106 CFU 
could be released from the sponge after applying light pressure. After each administration of 
bacteria the tail was held down for at least 10 min to prevent defecation and removal of the 
inoculum. Group 5 (n=2) did not receive the primary inoculum, but was co-penned with culture-
positive sheep 30 days post primary inoculation (dppi) to serve as naturally exposed age-
matched controls. On 98 dppi, the animals from groups 3, 4 and 5 were re-infected by the 2-
days-sponge method. The experimental design is presented in Figure 1. 
Experiment 2 
A second experiment was performed to determine the localization of E. coli O157:H7 in 
the gastrointestinal tract after rectal inoculation with the 2-days-sponge method, and to analyse 
local and cellular immune responses. Thirteen sheep were divided into 3 groups: a re-infected 
group (n=5), a previously unexposed group (n=3) and a control group (n=5). Animals in the re-
infected group received a primary and secondary inoculation on days 0/1 and days 41/42 
respectively, whereas animals in the previously unexposed group were only inoculated on days 
41/42. Control animals were not inoculated. The experimental design is presented Figure 1. One 
control and one infected animal (re-infected group) were euthanized on 8 dppi and again on 15 
dppi, by captive bolt gun stunning, followed by exsanguination. Intestinal contents were sampled 
from rectum, colon, caecum, ileum and jejunum, for bacterial enumeration and determination of 
local antibody responses.  
Faecal excretion of E. coli O157:H7 and serum antibody responses were assessed as in 
experiment 1. Additionally, each time when faeces was taken for bacterial enumeration, 1 g 
faeces was processed for determination of faecal antibodies as described below. Furthermore, 
blood was taken on 9, 16 and 41 dppi (just before administration of the secondary inoculation), 
Rectal inoculation of sheep with E. coli O157:H7 
53 
and 5 days after the secondary inoculation (46 dppi) to determine lymphocyte proliferative 
responses. 
1.3.4. Monitoring of E. coli O157:H7 excretion 
Faecal excretion of E. coli O157:H7 was monitored by direct plating and immunomagnetic 
separation (IMS) according to the method described by Tutenel et al. (2003) for isolation of 
E. coli O157:H7 from cattle faeces. The detection limit of E. coli O157:H7 in sheep faeces was 
determined to be 102 CFU/g by direct plating and 101 CFU/g by IMS (data not shown). Nalidixic 
acid (15 µg/ml) was included in cefixime-tellurite sorbitol MacConkey agar (NalCT-SMAC) to 
facilitate recognition of NCTC12900 colonies. Briefly, 10 g faeces was diluted in modified 
tryptone soy broth supplemented with 20 mg/ml novobiocin and homogenized in a stomacher 
blender. Ten-fold dilution series were plated onto NalCT-SMAC. The remaining broth was 
enriched for 6h at 42°C and subjected to IMS with O157 Dynabeads® (Invitrogen, Merelbeke, 
Belgium) according to the manufacturer’s instructions. Finally, 100 µl was plated onto NalCT-
SMAC. Colonies were confirmed to be E. coli O157:H7 by latex agglutination test (Oxoid). Colony 
counts were log10 transformed for data analysis. If E. coli O157:H7 was not detected by direct 
plating but enrichment culture was positive by IMS, the lowest detectable concentration was 
assigned (101 CFU/g). Animals were considered negative after 2 successive negative IMS results. 
1.3.5. Recombinant His-tagged virulence factors 
Plasmids pCVD468 and pCVD469 (kind gift of Dr. D. Karpman, Lund, Sweden) were used 
for recombinant expression of respectively EspA and EspB as described earlier (Karpman et al., 
2002). Plasmid pMW103 (kind gift of Dr. A. O’Brien, Bethesda, U.S.) was used to express the C-
terminal 380 amino acids of intimin-γ (referred to as intimin) as previously described (Sinclair 
and O'Brien, 2002). 
1.3.6. ELISA for determination of antibodies against virulence factors of E. coli O157:H7 
Serum samples were heat-inactivated (30 min. at 56°C) and kaolin-treated for use in 
ELISA tests. Polysorp 96-well plates (Nunc, Roskilde, Denmark) were coated with 200 ng/well of 
intimin, EspA or EspB in PBS for 2h at 37°C and blocked overnight at 4°C with PBS + 0.2% 
Tween®80. After washing with PBS + 0.2% Tween®20, plates were incubated with serum samples 
in 2-fold dilution series, followed by isotype-specific anti-sheep HRP conjugates (anti-IgG, anti-
IgA, anti-IgM, all from AbD Serotec, Düsseldorf, Germany). The buffer for dilution of samples and 
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conjugates was PBS + 3% BSA for the IgG ELISA, and PBS + 0.05% Tween®20 + 3% BSA for IgA and 
IgM ELISA tests. Each incubation step of 1h at 37°C was followed by 3 washes. After addition of 
2,2’-azino-di-[3-ethylbenzthiazoline sulfonate] diammonium salt (ABTS) (Roche Diagnostics, 
Vilvoorde, Belgium), the optical density was measured at 405 nm (OD405). Endpoint titres were 
defined as the inverse of the highest dilution where the optical density still exceeded the cut-off 
value, with cut-off = mean OD405 + 3 × standard deviation of OD405 values of day 0 sera from all 
sheep. Sera from animals intramuscularly immunized with intimin, EspA and EspB were used as 
positive controls. 
Faecal samples and intestinal contents were diluted ½ (w/v) in PBS supplemented with 
2% normal horse serum, penicillin (100 I.U./ml), streptomycin (100 μg/ml) and 0,2% Tween®20 
and heat inactivated. The supernatant obtained after centrifugation was tested in ELISA as 
described above. 
1.3.7. Lymphocyte proliferation test 
Peripheral blood was collected from the jugular vein on heparin (50 I.U./ml blood) and 
centrifuged (1000xg at 18°C for 25 min). Peripheral blood monomorphonuclear cells (PBMC) 
were isolated from the buffy coat by density gradient centrifugation (800×g at 18°C for 45 min) 
on Lymphoprep® (Nycomed Pharma AS, Life Technologies, Merelbeke, Belgium) and collected 
from the interphase. After lysis of erythrocytes in ammonium chloride (74.7%) and subsequent 
centrifugation (380×g at 4°C for 10 min), the pelleted cells were washed and resuspended at the 
desired concentration in leucocyte medium (RPMI-1640 (Gibco, Life Technologies, Merelbeke, 
Belgium) containing  FCS (10%), 2-mercaptoethanol (5×10−5 M), non-essential amino acids 
(100 mM), Na-pyruvate (100 μg/ml), L-glutamine (292 μg/ml), penicillin (100 I.U./ml), 
streptomycin (100 μg/ml) and kanamycin (100 μg/ml)). PBMC were seeded in triplicate at 5 x 105 
cells/well in sterile 96-well plates and stimulated with 3 µg/well of intimin, EspA or EspB, 0.5 
µg/well ConA as positive control or with medium alone as negative controle. After 4 days 
incubation at 37°C, 1 µCi 3H-thymidine was added to each well and the plates were incubated 
for another 18h at 37°C. Cells were harvested on glass fibre filters and the incorporated 
radioactivity was measured using a beta scintillation counter (Perkin-Elmer). Results are 
expressed as geometrical mean counts per minute (CPM). 
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1.3.8. Statistics 
Data from the proliferation tests performed during experiment 2 were analysed with 
SPSS17 using one-way ANOVA with least significant difference (LSD) post hoc tests to compare 
the proliferative responses between different groups of animals. A p-value < 0.05 was 
considered statistically significant. 
1.4. Results 
1.4.1. Excretion of E. coli O157:H7 following rectal inoculation of sheep 
In the first experiment, 4 different rectal inoculation methods were tested. All inoculated 
animals excreted E. coli O157:H7 in the faeces during at least 16 days (data not shown). 
Inoculation via a syringe (group 1 and 2) resulted in variable duration of shedding, irrespective of 
low (16-48 days) or high dose (16-70 days). Group 3 which was inoculated once with the sponge, 
showed the shortest (16-27 days) excretion, whereas group 4 which received the sponge on 2 
consecutive days showed the longest (48-78 days) excretion (Figure 1b). One animal in group 4 
remained positive by direct enumeration up to day 55. Therefore, the 2-days-sponge method 
was used in further experiments. The contact-exposed animals showed excretion in low amounts 
(between 101 and 102 CFU/g), as shedding was only detectable by IMS (Figure 1b). 
To determine if animals could be re-infected, the animals from groups 3 and 4 
(respectively short and long excretion after primary inoculation) were re-inoculated at day 98 ppi 
(i.e. 3 weeks after ceasing of shedding in all animals) by the 2-days-sponge method. The contact-
exposed animals were also inoculated at this time, to account for possible differences resulting 
from experimental (rectal) versus natural (oral) infection. All animals became colonized and shed 
for 9 to 33 days (Figure 1b), with no clear differences between the groups in terms of duration of 
shedding. Each individual animal in groups 3 and 4 shed an equal or lower number of days after 
the secondary inoculation compared to the primary inoculation. 
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A second experiment was performed to repeat the 2-days-sponge method, to determine 
the localization of E. coli O157:H7 and to further investigate the effect of re-infection on immune 
responses (discussed below). Sheep were rectally inoculated by the 2-days-sponge method and 
excreted E. coli O157:H7 for 7 to 22 days. Six weeks after the primary inoculation, these animals 
were re-infected, and a group of previously unexposed animals was inoculated at this time to 
investigate the effect of age on shedding. Re-infected animals excreted during 12 to 76 days, 
whereas previously unexposed animals excreted during 23 to 41 days (Figure 2b). The control 
group was not inoculated and remained negative throughout the experiment. 
 
Figure 1: Experiment 1. (a) Timeline: primary inoculations were administered at 0 dppi, by different methods and 
doses; secundary inoculations were administered at 98 dppi by the 2-days-sponge method. Black arrows: 
experimental inoculation; grey arrow: natural infection by contact exposure to culture positive sheep. (b) 
Excretion of E. coli O157:H7 following primary and secondary inoculation of 3 groups of sheep by different 
methods. Results are presented as average values of animals in a group. CFU: colony forming units. Dppi: days post 
primary inoculation. 
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1.4.2. Localization of E. coli O157:H7 after rectal infection 
In experiment 2, the intestinal localiation of E. coli O157:H7 was determined at 8 and 15 
dppi. E. coli O157:H7 was recovered from the intestinal content of infected animals, and not 
from control animals on both time points. E. coli O157:H7 was found in intestinal content from 
the caecum, colon and rectum, but was not recovered from the small intestine as samples taken 
from the jejunum and ileum were negative after enrichment. Whereas rectal contents were 
positive by direct plate counts, with 5.00 x 102 CFU/g and 2.30 x 103 CFU/g detected on 8 and 15 
dppi respectively, colon and caecum contents were only positive after enrichment culture and 
IMS, indicating bacterial levels lower than 102 CFU/g. 
  
 
Figure 2: Experiment 2. (a) Timeline. Arrows indicate experimental inoculation, stars indicate euthanasia of one 
animal. (b) Excretion of E. coli O157:H7 following primary and secondary rectal inoculation of sheep by the 2-days-
sponge method. Closed symbols represent animals from the re-infected group (animals 4307, 4309 and 4293), 
open symbols represent previously unexposed animals (animals 4322, 4289 and 4298). Results are presented as 
average values of animals in a group. Dppi: days post primary inoculation. 
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1.4.3. Analysis of serum antibody responses 
Serum samples obtained in both experiments were tested for the presence of antibodies 
against intimin, EspA and EspB. Figure 3 shows the IgG response of animals infected by the 2-
days- and 1-day-sponge method, and by contact exposure (experiment 1). IgG titres were low to 
absent, with a maximum titre of 20 in any of the animals. IgG titres in experiment 2 were 
similarly low and IgA or IgM were not detected in both experiments (data not shown). There was 
no difference between infected or non-infected animals, nor was there any effect of re-infection. 
 
 
Figure 3: Serum antibody responses following rectal inoculation of animals infected by the 2-days-sponge method, 
1-day-sponge method and contact exposure (experiment 1). Results are presented as average log2 values of titres. 
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1.4.4. Local intestinal antibody responses 
Intestinal contents from rectum, colon, caecum, ileum and jejunum were tested for 
intimin-, EspA- and EspB-specific IgA, to determine the presence of a local immune response. 
However, IgA was not detected in any of the samples. Faecal antibodies were not detected 
either (data not shown). 
1.4.5. Lymphocyte proliferation 
In experiment 2, lymphocyte proliferation was measured at 9 and 16 dppi, immediately 
before (41 dppi) and 5 days after the secondary inoculation (46 dppi) (Figure 4). Animals in the 
previously unexposed group were only inoculated at 41 dppi and can be regarded as uninfected 
animals before 41 dppi. At 9 dppi, the proliferative responses against intimin, EspA and EspB 
were higher in infected animals than in uninfected animals, and this response was significant for 
EspA (p < 0.05). Two out of three infected animals were excreting E. coli O157:H7 at that time. At 
16 dppi, all animals had stopped shedding and lymphocyte proliferation in the infected animals 
decreased, but remained higher than in uninfected animals, with a significant difference for the 
response against intimin (p < 0.05). At 41 dppi, responses against all antigens decreased further 
and re-inoculation did not enhance proliferation at 46 dppi. The previously unexposed animals 
were inoculated at 41 dppi, but did not show a proliferative response that was significantly 




Figure 4: Lymphocyte proliferation of peripheral blood monomorphonuclear cells (PBMC) of rectally inoculated 
sheep after in vitro stimulation with virulence factors of E. coli O157:H7. Results are presented as counts per 
minute (CPM) ± SEM. *: significant differences (p < 0.05) between the re-infected group and the other groups. 
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1.5. Discussion 
Our goal was to develop a rectal inoculation model leading to persistent E. coli O157:H7 
infection of sheep, and to use this model to study immune responses occurring after infection. 
Other investigators have attempted rectal inoculation of cattle and sheep (Sheng et al., 2004; 
Best et al., 2009) for different purposes. Best et al. (2009) inoculated sheep rectally using a liquid 
inoculum, but they did not monitor excretion for more than 2 weeks. In the present study, 
excretion was monitored until it was no longer detectable by a sensitive IMS method. In the first 
experiment, the 2-days-sponge method resulted in long duration of excretion (48-78 days), 
similar to excretion patterns reported after natural infection (Kudva et al., 1997a; Widiasih et al., 
2004a). Therefore, this method was used to study the immune response of sheep in the second 
experiment. However, even though experimental procedures were repeated exactly and animals 
were of the same age as in the first experiment, excretion after primary inoculation in the 
second experiment was of shorter duration (7-22 days). On the other hand, previously 
unexposed age-matched animals shed for 23 to 41 days. Thus, excretion of E. coli O157:H7 after 
rectal inoculation appears to be variable, as has been reported for oral inoculation experiments 
with E. coli O157:H7 in cattle and sheep (Cray and Moon, 1995; Sanderson et al., 1999; Cookson 
et al., 2002; Sheng et al., 2004).  
Sheng and co-workers (2004) reported that E. coli O157:H7 colonization remained limited 
to the rectoanal junction in cattle that were rectally inoculated by swabbing the rectal mucosa. 
Although we applied a similar local inoculation method in sheep using a sponge, colonization 
extended to the distal large intestine and was not solely confined to the rectal mucosa. Our 
results confirm that E. coli O157:H7 colonises the ovine rectal mucosa less exclusively than in 
cattle (Best et al., 2009). 
Strain NCTC12900 is a naturally occurring strain and was previously described and 
characterised in in vitro and in vivo models (Dibb-Fuller et al., 2001; Wales et al., 2002; 
Woodward et al., 2003). It does not possess Shiga toxins, but it was reported that Shiga toxin 
does not facilitate E. coli O157:H7 colonization in sheep and cattle (Sheng et al., 2006b; Cornick 
et al., 2007). On the other hand, it has been shown that Stx can suppress the lymphocyte 
proliferation response (Hoffman et al., 2006). Infection studies with Shiga toxin-positive strains 
are needed to further elucidate the influence of Shiga toxin and other virulence factors on 
immune responses of ruminants against E. coli O157:H7.  
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Sedgmen and co-workers (2002) describe the presence of lymphoid follicles in the rectal 
mucosa of sheep, similar to Peyer’s patches, which are known induction sites of mucosal 
immune responses. However, we were unable to detect serum, intestinal or faecal antibodies 
after rectal inoculation of sheep with E. coli O157:H7, indicating that rectal inoculation does not 
induce humoral responses. Nevertheless, cellular responses as measured by proliferation tests 
were demonstrated early after primary infection, with a marked response against EspA and 
intimin. However, the existence of a cellular response did not prevent re-infection. It was 
speculated that reduced excretion of E. coli O157:H7 in cattle after re-infection can be explained 
by the rise of a protective immune response (Sanderson et al., 1999; Naylor et al., 2007). Our 
results show that E. coli O157 can persist in sheep as seen in cattle, with re-infection occurring 
after a secondary inoculation but without the rise of a clear antibody response after rectal 
inoculation. 
As serum antibodies have been described after oral experimental infection (Johnson et 
al., 1996; Bretschneider et al., 2007b), it is possible that E. coli O157:H7 has to interact with the 
lymphoid tissue of the small intestine to induce clear immune responses. However, data from 
experimental infection studies should be carefully interpreted as they are often derived from 
animals with pre-existing antibody titres (Johnson et al., 1996; Bretschneider et al., 2007b). To 
our knowledge, this is the first study to evaluate O157-seronegative sheep combined with the 
study of immune responses and long-term monitoring of excretion. Rectal inoculation does not 
lead to humoral immune responses in young sheep, but induces cellular responses, particularly 
to EspA and intimin. It remains to be determined whether this cellular response is suppressing 
the humoral immunity and thus could explain the persistent infection of E. coli O157:H7. 
1.6. Conclusion 
Rectal inoculation of sheep with E. coli O157:H7 leads to infection of the lower 
gastrointestinal tract, in the absence of a protective immune response. 
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Chapter 2: 
Oral infection with a Shiga toxin-negative E. coli O157:H7 
strain elicits humoral and cellular responses but does not 
protect sheep from colonization with the homologous strain  
Based on: Vande Walle K., De Zutter L., Cox E., 2010. Oral infection with a Shiga toxin-negative E. coli 
O157:H7 strains elicits humoral and cellular responses but does not protect sheep from colonization with 
the homologous strain. Veterinary Microbiology, in press, doi:10.1016/j.vetmic.2010.09.012.  
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2.1. Abstract 
We have previously shown that rectally inoculated sheep excrete E. coli O157:H7 during 
weeks to months without developing a clear antibody response. However, antibodies against 
this bacterium were observed in naturally infected sheep, which most likely became orally 
infected. To understand this difference, sheep were orally inoculated with the same Shiga toxin-
negative E. coli O157:H7 strain that was used for the rectal inoculation. A primary oral 
inoculation resulted in shedding of E. coli O157:H7 in the faeces and detection of antibody 
responses against intimin, EspA and EspB. The antibody titres waned as shedding decreased. A 
secondary inoculation resulted in longer shedding, even though a booster antibody response 
occurred. Cellular responses followed a similar pattern as the antibody levels, albeit with a lower 
secondary response. The presence of antigen-specific antibody-secreting cells indicates 
involvement of both a systemic response in the spleen and a local immune response in the 
terminal rectum. These results suggest that E. coli O157:H7 has to pass the small intestine to 
evoke antibody responses. 
2.2. Introduction 
E. coli O157:H7 is a foodborne pathogen posing an important public health risk (Rangel et 
al., 2005). Therefore, contamination with E. coli O157:H7 may have important economical 
consequences due to withdrawal of food from the market (Stevens et al., 2002a). Ruminants 
constitute the major reservoir, harbouring the bacteria in the gastrointestinal tract without 
showing clinical symptoms (Caprioli et al., 2005). Faecal shedding patterns of E. coli O157:H7 by 
ruminants have been extensively studied (Besser et al., 1997; Cookson et al., 2002; Naylor et al., 
2007) and excretion can be detected during several months (Cray and Moon, 1995; Liebana et 
al., 2005). The reason for this persistence remains unclear, although several studies suggest a 
suppression of the host immune system by E. coli O157:H7. Indeed, Shiga toxin (Stx) has been 
observed to suppress the activation of bovine lymphocytes in vitro (Menge et al., 1999), and to 
decrease specific cellular immune responses in cattle during infection with E. coli O157:H7 
(Hoffman et al., 2006). Furthermore, EspJ, an effector molecule inserted into the host cell by the 
type III secretion system, is known to inhibit opsono-phagocytosis of E. coli O157:H7 by 
macrophages (Marches et al., 2008). In addition, E. coli O157:H7 contains a functional 
homologue of lymphostatin (Abu-Median et al., 2006), a toxin of the related enteropathogenic 
E. coli (EPEC), which inhibits human lymphocyte proliferation and cytokine expression in 
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response to mitogen stimulation (Klapproth et al., 2000). Moreover, Hu and co-workers (2009) 
recently showed a specific block in antibody secretion by the subtilase cytotoxin of E. coli 
O157:H7. However, only limited in vivo data are available (Hoffman et al., 2006). The aim of our 
research is to study the immune response of sheep against E. coli O157:H7. We previously 
demonstrated that rectal inoculation with E. coli O157:H7 induced a cellular immune response 
without evoking antibody responses against intimin, EspA or EspB even though the bacteria were 
excreted during a long period of time (48 to 78 days) (Vande Walle et al., 2010a). However, 
antibodies against these proteins were observed in the serum of naturally infected sheep (Vande 
Walle et al., unpublished data). Therefore, in the present study we analysed excretion and 
immune responses against E. coli O157:H7 following oral inoculation, which resembles more the 
natural route of infection. 
2.3. Material and methods 
2.3.1. Bacterial inoculums 
NCTC12900 is a well characterized Stx-negative E. coli O157:H7 strain with spontaneous 
nalidixic acid resistance (Dibb-Fuller et al., 2001; Wales et al., 2002; Woodward et al., 2003). For 
preparation of bacterial inocula, NCTC12900 was grown overnight in Luria Bertani broth at 37°C 
while shaking (200 rpm), washed with sterile phosphate-buffered saline (PBS) and resuspended 
in 10% saccharose (Merck) solution. 
2.3.2. Experimental animals and procedures 
Eight ten-week-old conventionally reared sheep (Belgian cross-breed, Zootechnical 
Centre, Leuven, Belgium), culture negative for E. coli O157:H7 in faeces (on 2 separate occasions) 
and seronegative for antibodies against intimin, EspA and EspB, were allowed to acclimatize for 
one week after arrival in our facilities. Sheep received rye-grass silage supplemented with a 
grain-based pelleted diet (mainly barley, corn, alfalfa and oat) and water ad libitum. The sheep 
were housed in groups with four animals per pen. 
After the acclimatization period, lambs were orally given colistin at 50.000 I.U./kg body 
weight (Promycine pulvis 1 million I.U./g, VMD, Berendonk, Belgium), twice daily during 5 days, 
to prevent E. coli infections due to handling and transport of the animals. Prior to the inoculation 
(2 days after the last colistin dose), lambs were given a 10% NaHCO3 solution via a nursing bottle, 
to close the oesophageal groove in order to direct the inoculum into the abomasum. Four 
animals were inoculated orally with 1010 CFU of NCTC12900. The inoculum was given on two 
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consecutive days, as for the rectal infection model (Vande Walle et al., 2010). The other four 
lambs served as a negative controls and received the NaHCO3 and saccharose solution but not 
the inoculum. Faecal excretion of NCTC12900 was monitored by direct plating and 
immunomagnetic separation (IMS) as described (Vande Walle et al., 2010a). Excretion was 
initially monitored three times per week, and this sampling frequency was gradually reduced to 
once a week as shedding decreased. Thirty-six days after ceasing of shedding in the longest 
shedding animal (66 days post primary inoculation, dppi), the four lambs were re-inoculated in a 
way identical to the primary inoculation, to determine the presence of protective immunity. 
Recombinant intimin, EspA and EspB were produced as described to analyse the immune 
responses against these virulence factors (Karpman et al., 2002; Sinclair and O'Brien, 2002; 
Vande Walle et al., 2010a). Serum was sampled weekly to monitor antibody responses by ELISA 
(Vande Walle et al., 2010a) and blood on days 17, 38, 56, 76, 85 and 100 post primary 
inoculation (dppi) to monitor cellular immune responses. One animal was euthanized 40 days 
after the secondary inoculation (106 dppi) to determine the intestinal localization of NCTC12900. 
Hereto, intestinal contents and tissues (rumen, duodenum, jejunum, ileum, caecum, colon and 
rectum) were tested for the presence of NCTC12900 by direct plate counts and IMS as described 
for faecal samples. Before testing, tissues were carefully rinsed with sterile PBS to remove non-
adherent bacteria. Intestinal contents were also tested in ELISA for the presence of antibodies 
(Vande Walle et al., 2010a). Three animals were euthanized 74 days after the secondary 
inoculation (140 dppi) when all animals had stopped shedding to localize the immune response 
by determining antibodies in intestinal contents and the number of antibody-secreting cells 
(ASC) in different tissues: spleen, mesenterial (MLN), colonic (CoLN) and rectal lymph nodes 
(RLN), Peyer’s patches from the jejunum (JPP) and ileum (IPP), lamina propria of the jejunum 
(LPJ) and the rectum (LPR). The remaining animals were euthanized at 140 dppi without further 
sampling. All experimental and animal management procedures were approved by the Animal 
Care and Ethics Committee of the Faculty of Veterinary Medicine, Ghent University. 
2.3.3. Evaluation of the cellular immune response: proliferation test 
Peripheral blood monomorphonuclear cells (PBMC) were isolated from blood as 
described (Vande Walle et al., 2010a), seeded in triplicate at 5 x 105 cells/well in sterile 96-well 
plates and stimulated with 100 µg/ml intimin, 100 µg/ml EspA and 25 µg/ml EspB. After 4 days 
incubation at 37°C, 1 µCi 3H-thymidine was added to each well and the plates were incubated for 
another 18h at 37°C. Cells were harvested on glass fibre filters and incorporated radioactivity 
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was measured using a beta scintillation counter (Perkin-Elmer, Brussels, Belgium). Results are 
expressed as stimulation indices (SI): geometric mean of stimulated wells/geometric mean of 
unstimulated wells. Stimulation with 0.5 µg/well ConA and cell culture medium served as 
positive and negative control, respectively. 
2.3.4. Isolation of monomorphonuclear cells (MC) from spleen, lymph nodes and 
intestine 
MC from spleen, MLN, CoLN, RLN, JPP and IPP were isolated essentially as described by 
Van den Broeck et al. (1999). Intestinal segments from the LPJ and LPR were washed with PBS + 
100 I.U./ml penicillin + 100 µg/ml streptomycin, and the serosa and the muscle layer were 
removed. The tissue was cut into 2-3 mm2 pieces and incubated three times for 40 minutes in 
Hank’s balanced salt solution (HBSS) with 0.94 M dithiotreitol, 2.52 M EDTA and 100 I.U./ml 
penicillin and 100 µg/ml streptomycin in a shaking incubator at 37°C followed by sieving the 
intestinal fragments. After rinsing the tissue with HBSS, it was incubated during 30 minutes in 
RPMI with 5% FCS, 20 mM HEPES, 0.1 mg/ml DNase I, 100 I.U./ml penicillin and 100 µg/ml 
streptomycin. Subsequently, the tissue fragments were incubated for 1h in the RPMI solution 
with 0.36 mg/ml collagenase A in a shaking incubator at 37°C. Then, the cell clumps were 
removed by filtration through a 70 µm cell strainer. The obtained MC from the different tissues 
were washed with PBS + 1 mM EDTA. Cells were resuspended in leucocyte medium at 5 x 106 
cells/ml. 
2.3.5. ELISPOT assay for antigen-specific IgG, IgA and IgM ASC 
Antigen-coated plates were prepared as described for the ELISA tests (Vande Walle et al., 
2010a). In addition to intimin, EspA and EspB, plates were coated with 100 µl/well of a sonicated 
NCTC12900 suspension (5 x 108 CFU/ml, further referred to as O157 lysate). Thereafter, MC 
suspensions at a concentration of 5 x 106 cells/ml were added (100 µl/well) and plates were 
incubated for 16 h at 37°C in a humidified 5% CO2 atmosphere. Subsequently, the cells were 
removed by ten washes with ELISA washing buffer and wells were incubated for 1h at 37°C with 
anti-sheep IgG-, IgA- or IgM- HRP conjugated secondary antibody (all from AbD Serotec, 
Düsseldorf, Germany). After incubation, the plates were washed 3 times with ELISA washing 
buffer. Next, a substrate solution, consisting of 4 volumes of 3-amino-9-ethylcarbazole (AEC) 
(Sigma, Bornem, Belgium) working solution (0,67 ml AEC stock solution (0,4% in 
dimethylformamide) in 10 ml Na acetate (0,1 M, pH 5,2) + 10 µl 30% H2O2) and 1 volume of 3% 
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low-melting-point agarose (BIOzym, Landgraaf, The Netherlands) was added. After overnight 
incubation in the dark at room temperature, spots were counted with an ELISPOT reader 
(Immunospot, CTL). For each MC suspension, spots in 5 wells were counted to obtain the 
number of isotype-specific ASC/2,5x106 MC. 
2.4. Results 
2.4.1. Excretion and intestinal localization of E. coli O157:H7 
Following the primary inoculation, excretion of E. coli O157:H7 in the 4 orally inoculated 
lambs lasted minimally 13 and maximally 30 days (Figure 1). Excretion was highest 3 to 10 days 
after inoculation and declined rapidly thereafter. The lambs were re-infected 36 days after 
ceasing of excretion in all animals (66 dppi). Excretion after this secondary inoculation lasted 
consistently longer than after the primary inoculation, varying from 28 to 69 days. Animal 4532 
was euthanized 40 days after the secondary inoculation (106 dppi), and was still excreting E. coli 
O157:H7 at that time. E. coli O157:H7 could be recovered from all sites throughout the intestine: 
rumen, duodenum, jejunum, ileum, colon, caecum and rectum. Intestinal content and tissue 
parts from all sites except the rectum were only positive after enrichment culture, indicating 
bacterial counts between 101 and 102 CFU/g. However, intestinal content of the rectum was 
positive for E. coli O157:H7 in direct plate counts, with 1.035 x 104 CFU/g. 
 
 
Figure 1: Excretion of E. coli O157:H7 of orally inoculated sheep. Results are presented as log10 values of colony 
forming units (CFU)/g faeces. Arrows indicate time of  inoculations. E. coli O157:H7 was never recovered from any 
of the control animals. † euthanasia of animal 4532 at 106 dppi. Dppi: days post primary inoculation. 
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2.4.2. Antibody responses 
Serum was sampled weekly to evaluate the antibody responses against intimin, EspA and 
EspB. The infected animals responded against the infection by producing IgG against all three 
antigens (Figure 2). The IgG titres reached a peak around 3 weeks post primary inoculation and 
decreased as the shedding levels declined (Figure 1). Following the secondary inoculation the 
titres against EspA and EspB rapidly rose again, indicating a secondary immune response. This 
was most pronounced for EspA whereas only a weak response was observed against intimin. 
These responses could not be considered as real secondary responses, which are characterized 
by higher titres and occur faster after contact with antigens than a primary response. Overall, 
animals 4531 and 4533 responded with the highest antibody titres whereas animals 4532 and 
4575 only showed low responses (individual data not shown). Serum IgM or IgA antibodies were 
not detected in any of the animals and the control animals remained seronegative throughout 
the experiment (data not shown). 
 
Figure 2: Serum IgG antibody responses of orally inoculated sheep against intimin, EspA and EspB. Results are 
presented as log2 titers ± SEM. Arrows in icate time of inoculations. Dppi: days post primary inoculation. 
 
To localize and quantify the antibody response following EHEC infection, two infected animals 
that showed clear serum antibody responses (4531 and 4533) and one control animal were 
euthanized at 140 dppi. Antigen-specific IgG or IgA could not be detected in the intestinal 
contents. However, antigen-specific ASC were detected in the spleen and the rectal lamina 
propria of the infected animals (Table 1) but not in the other tissues. Animal 4531 which had 
stopped excreting E. coli O157:H7 five days before euthanasia, showed a clear IgM and IgG 
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response in the spleen and an IgA response in the rectal lamina propria that was stronger than 
the IgG response at this site. Animal 4533 which ceased excreting 41 days earlier, showed lower 
responses with only two O157-specific IgG ASC in the spleen and two IgG and six IgA O157-
specific cells, probably reflecting the waning immune response due to the longer absence of 
infection. 
 
2.4.3. Lymphocyte proliferation 
To analyse cellular responses, PBMC isolated at different time points after primary and 
secondary inoculation were restimulated in vitro with intimin, EspA and EspB (Figure 3). 
Proliferative responses against intimin were high at 17 dppi, whereafter this response gradually 
declined. Re-infection at 66 dppi did not result in an increase of the intimin-specific proliferation. 
Responses after stimulation with EspA and EspB were highest at 38 dppi, when shedding had 
already ceased in all animals. Re-infection seemed to cause a second rise in these responses, 
although they were lower than at 38 dppi. However, the control animals also showed 
proliferation after stimulation with EspA and EspB although E. coli O157:H7 excretion or serum 
responses were not detected. This suggests that cross-reacting antigens primed the immune 
system. 
Table 1: Number of antigen-specific ASC per 2.5 x 10
6
 cells in different tissues of infected animals and a control 
animal, euthanized at 140 days post primary inoculation. 
   IgG  IgA  IgM 
Animal  Tissue  Int A B O157  Int A B O157  Int A B O157 
4531  Spleen  7 + 6 0  0 + 0 1  11 17 0 7 
  LPR  5 0 0 24  19 0 0 46  0 0 0 0 
4533  Spleen  0 0 0 2  0 0 0 0  0 0 0 0 
  LPR  0 0 0 2  0 0 0 6  0 0 0 0 
Control  Spleen  0 0 0 0  0 0 0 0  0 0 0 0 
  LPR  0 0 2 0  0 0 0 0  0 0 0 0 
Int: intimin, A: EspA, B: EspB, O157: lysate of E. coli O157:H7, +: unquantifiable colour reaction (different from 
background), LPR: lamina propria of the rectum. 
 





Figure 3: Lymphocyte proliferation after stimulation with intimin, EspA and EspB on different time points after oral 
infection. Inoculations were performed on days 0/1 and 66/67. Results are presented as stimulation index ± SEM. 
Black bars: average of values of infected animals (n=4), white bars: average of values of control animals (n=4). 
Arrows indicate time of inoculations. Dppi: days post primary inoculation. 
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2.5. Discussion 
We used an oral infection model to analyse immune responses against E. coli O157:H7 
and compared the results with a previously described rectal inoculation model (Vande Walle et 
al., 2010a). Although antibody responses were only present following oral inoculation, cellular 
responses were present following both rectal and oral inoculation (Vande Walle et al., 2010a and 
this study). In the present study, proliferative responses were high shortly after the primary 
inoculation and decreased as shedding disappeared. The results suggest that the cellular 
response against intimin could be more specific for an E. coli O157:H7 infection than the 
response against EspA and EspB, as the control animals showed a reaction against the latter two 
proteins in the absence of an identifiable E. coli O157:H7 infection or antibody response. 
However, the intimin-specific cellular response was not evoked by the secondary inoculation, 
whereas this was the case for the responses against EspA and EspB. Therefore, it cannot be 
excluded that contact with cross-reacting antigens provoked this secondary response. Indeed, 
EspA and EspB are not specific for EHEC, and are present in e.g. STEC and EPEC with high amino 
acid-similarity between EHEC and EPEC proteins (Abe et al., 1997; Ebel et al., 1998). Data 
regarding the cellular immune response against E. coli O157:H7 in ruminants are sparse. The 
only study performed so far in cattle reported a suppression of lymphocyte proliferation against 
heat-killed O157-antigens, mediated by Stx (Hoffman et al., 2006). In the present study, we 
infected sheep with an Stx-negative strain and did not find indications for lymphocyte 
suppression since proliferative and antibody responses were present after the primary and 
secondary inoculation. However, to obtain insight in the role of Stx, experiments with Stx-
positive strains should be performed. 
Whereas serum or intestinal antibodies were not detected after rectal inoculation even 
though excretion of E. coli O157:H7 persisted for several weeks to months (Vande Walle et al., 
2010a), in the present study a clear antibody response was seen in orally inoculated sheep. 
Antibody titres against intimin, EspA and EspB increased after the primary inoculation, and 
decreased as shedding diminished. A higher secondary response occurred against EspA and to a 
lesser extent against EspB after the secondary inoculation, with sustained antibody titres even 
though shedding ceased. Since the infected animals could be recolonized, these data suggest 
that the antibody response was not protective or that mucosal protection was limited. This was 
reflected by the observation that one infected animal that only recently ceased shedding 
showed antigen-specific IgA and IgG ASC in the lamina propria of the rectum, whereas another 
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animal that ceased shedding several weeks before barely showed ASC. Moreover, the antibody 
response in the intestinal tract seems to be quite local as antigen-specific ASC were only 
detected in the rectal mucosa, and not in the draining lymph nodes or in the small intestine. 
However, significant amounts of antigen apparently reach the systemic immune system as 
reflected by the presence of antigen-specific ASC in the spleen and serum antibody responses. 
Whereas after rectal inoculation E. coli O157:H7 was present only in the lower 
gastrointestinal tract (Vande Walle et al., 2010a), it could be found throughout the entire 
intestinal canal after oral infection. Our results indicate that in sheep colonization of the small 
intestine or interaction with the lymphoid tissue in the small intestine is necessary for a clear 
antibody response, but also seem to suggest that this antibody response is not involved in 
protection against infection. Peyer’s patches in the small intestine are known induction sites of 
mucosal immune responses. At the moment it is not clear why we could not find E. coli O157:H7-
specific ASC in other intestinal tissues than the rectal lamina propria and if this localized 
response explains the absence of correlation between antibody response and protection. It 
should be noted that at the time the local immune response was assessed, shedding had already 
stopped in all animals. Testing at different time points following infection would be interesting to 
provide a more complete and clearer picture of the ongoing immune response. Our results 
concur with the studies performed in cattle experimentally inoculated with E. coli O157:H7 
where infiltration of granulocytes in the rectal lamina propria and rectal IgA antibodies 
recognizing several O157 antigens were demonstrated (Bretschneider et al., 2008; Nart et al., 
2008a; Nart et al., 2008b). As shown before in cattle and now in sheep, pre-existing serum 
antibodies, whether from natural exposure or experimental infection, are not sufficient for 
protection (Johnson et al., 1996; Bretschneider et al., 2007b, this study). The role of the immune 
response during the course of infection and during clearance remains to be determined. To our 
knowledge, the rectal and oral inoculation studies performed in our lab (Vande Walle et al., 
2010a and this study), are the first studies to investigate immune responses of sheep against 
E. coli O157:H7.  
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Chapter 3: 
A preliminary investigation of the role of the immune 
system in clearance of E. coli O157:H7 infection in sheep 
Based on: Vande Walle K., Entrican G., Wattegedera S., De Zutter L., Vanrompay D., Cox E. A preliminary 
investigation of the role of the immune system in clearance of E. coli O157:H7 infection in sheep. 
Manuscript in preparation. 
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3.1   Abstract 
Previously, we demonstrated a serum antibody response and a cellular immune response 
against intimin, EspA and EspB following oral inoculation of sheep with E. coli O157:H7. 
However, these responses were not protective as sheep could become re-infected by the same 
strain. To investigate the role of the immune response in clearance of E. coli O157:H7, previously 
infected sheep were re-infected and euthanized when shedding declined. At that time, the 
systemic and the intestinal mucosal immune response against intimin, EspA, EspB and Tir were 
analysed. A subgroup of the infected animals had first been vaccinated with a mixture of these 
four antigens, to investigate the influence of preceding immunization. ELISPOT tests revealed 
mucosal antibody responses against EspA, in the jejunal Peyer’s patches of vaccinated animals 
and in the ileal Peyer’s patches of non-vaccinated animals. Following restimulation with the 
antigens, the regulatory cytokine IL-12 and the Th1 cytokine IFN-γ were only produced by spleen 
and lymph node cells, whereas monomorphonuclear cells from the Peyer’s patches and the 
rectal mucosa produced very low amounts or none of these cytokines. The pro-inflammatory 
cytokine TNF-α was produced by cells of all isolated tissues, but compared to control animals 
secretion was significantly lower by several cell types from non-vaccinated animals and by some 
cell types from vaccinated animals. The anti-inflammatory cytokine IL-10 showed the tendency 
to be higher in spleen, mesenteric and rectal lymph nodes of non-vaccinated animals whereas 
production was lower in mesenteric and rectal lymph nodes, and jejunal Peyer’s patches of the 
vaccinated animals. The results could suggest that infection with E. coli O157:H7 suppresses the 
inflammatory response by enhancing IL-10 production. Further research is needed to elucidate 
the interaction of E. coli O157:H7 with the mucosal immune system. 
3.2  Introduction 
E. coli O157:H7 is a foodborne pathogen transmitted by healthy ruminants. The bacteria 
colonize the gastrointestinal tract and are excreted in the faeces of ruminants, without overt 
symptoms (Paton and Paton, 1998). The absence of serious illness such as haemorrhagic colitis 
and the haemolytic uremic syndrome as seen in humans is attributed to the lack of the receptor 
for Shiga toxin on the microvasculature of ruminants (Pruimboom-Brees et al., 2000). Shedding 
of E. coli O157:H7 by ruminants is typically intermittent as demonstrated in longitudinal studies 
of excretion by naturally infected cattle (Robinson et al., 2004; Smith et al., 2010) but can be 
detected up to several months in individual animals following both natural and experimental 
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infection (Besser et al., 1997; Cornick et al., 2000, Vande Walle et al., 2010a; Vande Walle et al., 
2010b). In experimental infections, persistent infection is often defined as excretion for more 
than 14 days (Cookson et al., 2002; Woodward et al., 2003). The typical attaching and effacing 
(A/E) lesions that are formed in the human intestine upon colonisation, are only rarely observed 
in experimentally inoculated, persistently colonized animals (Wales et al., 2001a; Cookson et al., 
2002). Nevertheless, strains deficient in A/E colonization factors such as intimin and Tir, are less 
able to persist than the wild type strains (Cornick et al., 2002; Sheng et al., 2006b; Vlisidou et al., 
2006a; Bretschneider et al., 2007a), indicating important roles for these molecules in 
colonization.  
It has been suggested that E. coli O157:H7 can suppress the immune system of the 
ruminant host, thereby facilitating persistence in these species (Menge et al., 1999; Hoffman et 
al., 2006; Naylor et al., 2007). Nevertheless, immune responses against various proteins of E. coli 
O157:H7 have been demonstrated by us and others (Bretschneider et al., 2007b; Nart et al., 
2008a). We have shown that E. coli O157:H7 has to pass the small intestine to evoke antibody 
responses, as these responses were only observed after oral inoculation and not after rectal 
inoculation of sheep (Vande Walle et al., 2010a; Vande Walle et al., 2010b). However, in both 
cases cellular responses were present, which followed the course of infection. Neither antibody 
or cellular responses were protective, since sheep could be re-infected with the same E. coli 
O157:H7 strain. Nevertheless, eventually the shedding ceases and the infection is cleared. The 
factors leading to spontaneous clearance are unknown. The goal of the present study was to 
investigate which systemic or mucosal immune responses occur at the moment shedding ceases, 
in other words, what is the influence of the immune system on clearance of an E. coli O157:H7 
infection. In addition, because vaccination with E. coli O157:H7 colonisation factors is a possible 
strategy to decrease shedding in cattle and sheep (Potter et al., 2004; Atef Yekta et al., 2010) we 
investigated the influence of a preceding systemic immunization with intimin, EspA, EspB and Tir 
on the immune response and clearance of infection. 
3.3  Materials and methods 
3.3.1 Experimental animals and procedures 
A total of eleven conventionally reared sheep (Belgian cross-breed, Zootechnical Centre, 
Leuven, Belgium), negative for E. coli O157:H7 in faeces and seronegative for antibodies against 
intimin, EspA and EspB, were used in this experiment. The animals received hay supplemented 
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with a pelleted diet and water ad libitum. Seven of these sheep had previously been infected 
with the Shiga toxin-negative E. coli O157:H7 strain NCTC12900 (according to the method 
described by Vande Walle et al., 2010b), and three out of these seven sheep had first been 
intramuscularly immunized in the neck with intimin, EspA and EspB (100 µg each), formulated in 
incomplete Freund’s adjuvant (Atef Yekta et al., 2010). Booster immunizations with the same 
antigen mixture to which Tir was added were given 5 and 1 weeks before the experimental 
inoculation. This sequence of immunization, infection, and booster immunizations induced high 
serum antibody titres in these three sheep, which we considered as hyperimmunized animals. 
The seven previously infected sheep were orally re-infected with 1010 CFU of NCTC12900, on two 
consecutive days as described earlier (Vande Walle et al., 2010b). Four sheep served as negative 
controls and were not inoculated. An overview of the immunizations and experimental 
infections is presented in Table 1. At 5 days post inoculation (dpi), blood was taken to determine 
the presence of recirculating antibody-secreting cells (ASC). Weekly serum samples were taken 
to monitor the antibody response. On 0 and 19 days post infection (dpi) blood was taken to 
determine antigen-specific proliferation. Excretion of NCTC12900 was monitored in faeces twice 
weekly by direct plate counts and immunomagnetic separation (IMS) as described (Vande Walle 
et al., 2010a). When excretion was no longer detectable by direct plate counts, animals were 
euthanized to analyse the immune response. Colony counts were log10 transformed for data 
analysis and used to calculate area under the curve (AUC) values by the trapezoidal method 
(Naylor et al., 2007) to estimate the total amount of shedding during the monitoring period 
following re-infection. All experimental and animal management procedures were approved by 
the Animal Care and Ethics Committee of the Faculty of Veterinary Medicine, Ghent University 
(n° 2009/074). 
Table 1: Experimental design: overview of immunizations and infections. 
Group 
 
 n  First experiment 
(age sheep 4 months) 
(Atef Yekta et al., 2010) 
 Second experiment 




 4  - -  - - 
Vaccinated group 
 
 3  3x immunization with 
IAB 





 4  - O157  - O157 
IAB: immunization with intimin, EspA and EspB 
IABT: immunization with intimin, EspA, EspB and Tir 
O157: inoculation with E. coli O157:H7, strain NCTC12900 
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3.3.2 Recombinant proteins  
Intimin, EspA and EspB were produced as described (Karpman et al., 2002; Sinclair and 
O'Brien, 2002). Plasmid pET22bTir103 (kind gift of Dr. K. Gough, Leicester, U.K.) was used to 
express the intimin-binding domain of Tir (referred to as Tir) as described (Kuhne et al., 2004). 
3.3.3 ELISA for determination of antibodies against intimin, EspA, EspB and Tir 
ELISA assays for intimin, EspA and EspB were performed as described (Vande Walle et al., 
2010a), and an assay for Tir was developed with identical conditions. 
3.3.4 Antigen-specific proliferation assay 
Peripheral blood monomorphonuclear cells (PBMC) were isolated from blood and used in 
proliferation tests as described (Vande Walle et al., 2010b). PBMC were stimulated in vitro with 
100 µg/ml intimin, 100 µg/ml EspA, 25 µg/ml EspB or 100 µg/ml Tir. Results are expressed as 
stimulation indices (SI): geometric mean of stimulated wells/geometric mean of unstimulated 
wells. Stimulation with 0.5 µg/well ConA and cell culture medium served as positive and negative 
control, respectively. 
3.3.5 ELISPOT assay for antigen-specific IgG, IgA and IgM antibody-secreting cells 
(ASC) 
PBMC and monomorphonuclear cells (MC) from spleen, mesenteric (MLN), colonic 
(CoLN) and rectal lymph nodes (RLN), Peyer’s patches from the jejunum (JPP) and ileum (IPP), 
and lamina propria of the rectum (LPR) were isolated, resuspended at 1 x 106 cells/ml and used 
in ELISPOT assays to detect intimin-, EspA-, EspB- and Tir-specific ASC (Vande Walle et al., 
2010b). 
3.3.6 Cytokine production following in vitro restimulation of MC 
MC were seeded in triplicate at 1 x 106 cells/well in sterile 96-well plates and incubated 
with purified bacterial antigens: 100 µg/ml intimin, 100 µg/ml EspA, 25 µg/ml EspB, or 100 µg/ml 
Tir. The supernatant was collected after 72h incubation at 37°C in a humidified atmosphere. A 
TNF-α ELISA was performed with coating and capture antibodies from Perbio (Pierce, 
Erembodegem, Belgium) and ELISAs for IL-4, IL-10, IL-12 and IFN-γ were performed with 
antibodies from AbD Serotec (Düsseldorf, Germany) according to protocols used at the Moredun 
Institute (Hope et al., 2002; Kwong et al., 2002; Hope et al., 2005, S. Wattegedera, personal 
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communication). Quantification was performed using a standard curve generated using known 
concentrations of recombinant ovine cytokines (Moredun Institute, Edinburgh, Scotland). The 
cytokine concentrations were calculated using DeltaSOFT JV 2.1.2 software (BioMetallics, 
Princeton, NY, USA) with a 4-parameter curve-fitting algorithm applied for standard curve 
calculations. 
3.3.7 Statistics 
Data were analysed with SPSS17 using one-way ANOVA. A p-value < 0.05 was considered 
statistically significant. 
3.4  Results 
3.4.1 Excretion of E. coli O157:H7 
All re-infected sheep excreted E. coli O157:H7 in the faeces (Figure 1a and b). Although 
excretion values of vaccinated sheep were lower than those of non-vaccinated sheep, these 
were not significantly different at any time (p > 0.05). Animals were euthanized when shedding 
decreased and became detectable only by IMS, suggesting a possible imminent clearance of 
E. coli O157:H7. The vaccinated sheep were positive by direct counts up to 15 dpi (8 - 15 days) 
and by IMS up to 19 dpi. They were euthanized at 22 dpi. Three out of four non-vaccinated 
sheep were positive by direct counts up to 15 dpi (12 –15 days) and by IMS up to 19 dpi (15 – 19 
days). These three sheep were euthanized at 20 dpi, whereas the remaining non-vaccinated 
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3.4.2 Serum antibody responses and recirculating ASC 
Serum IgG titers were determined by ELISA (data not shown). Vaccinated animals showed 
high titres (6.32 – 10.32) against all antigens used for the intramuscular immunizations. In 
contrast, the titres of the non-vaccinated animals were low and similar to the titres of the 
control animals (3.32 – 4.32).  
To evaluate the presence of circulating ASC recognizing intimin, EspA, EspB or Tir, PBMC 
were isolated on 5 dpi (Table 3). No IgM ASC were detected as could be expected since the 
animals were re-infected and the vaccinated group had been hyper-immunized. The vaccinated 
animals showed IgG responses against intimin and EspA, likely reflecting the response after the 
intramuscular immunizations. However, there was no response against EspB and Tir. Three out 
of four non-vaccinated animals showed IgG responses against intimin and EspA, but lower than 
the response in the vaccinated animals. In contrast, IgA ASC specific for intimin and EspA were 
only detected in non-vaccinated animals. One non-vaccinated animal, 4897, was not responding 
at all. 
(b) 
Animals dpi 6 8 12 15 19 20 22 26 30 34 AUC 
Vaccinated            
 4931 3.15 2.30 2.00 2.00 1.00
a
  †    30.0 
 4948 4.62 1.00
a
 3.94 3.95 1. 00
a
  †    55.0 
 4946 4.54 2.00 1.00a 1.00a 1. 00
a
  †    36.7 
Non-vaccinated            
 4906 5.40 4.40 3.85 3.92 3.51   2.30 2.00 † 98.0 
 4942 7.17 4.20 5.21 2.70 0.00
b
 †     69.0 




 †     31.8 
 4897 2.78 2.48 3.04 3.40 1.00
a
 †     46.6 
 
Figure 1: Excretion of E. coli O157:H7 by control, vaccinated and non-vaccinated animals. a) Average log10 values of 
CFU/g faeces of animals in a group ± SEM. b) Individual log10 values (CFU/g faeces). AUC: area under the curve, 
estimation of the total amount of shedding. E. coli O157:H7 was not recovered from control animals at any time. 
Dpi: days post inoculation. 
a
 positive only by IMS, 
b
 negative by IMS, † euthanasia. 
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Table 3: Number of antigen-specific antibody-secreting cells per 5 x 10
6
 PBMC, isolated 5 days post inoculation from 
control and re-infected vaccinated and non-vaccinated sheep. 
Group  Intimin  EspA  EspB  Tir 
               Animal IgG IgA  IgG IgA  IgG IgA  IgG IgA 
Control            
 507 0 0  0 0  0 0  0 0 
 517 0 0  0 0  0 0  0 0 
 578 0 0  2 0  0 0  0 0 
 493 0 0  0 0  0 0  0 0 
Vaccinated            
 4931 65 0  49 0  4 0  0 0 
 4948 5 0  1 0  0 0  0 1 
 4946 13 0  6 0  0 0  1 0 
Non-vaccinated            
 4906 2 0  17 12  0 0  1 0 
 4942 9 4  0 0  0 2  0 0 
 4893 2 0  11 12  0 0  0 0 
 4897 0 0  0 0  0 0  0 0 
3.4.3 Lymphocyte proliferative responses 
Proliferative responses are presented in Figure 2. The vaccinated animals did not seem to 
show proliferation towards three out of the four antigens used for vaccination as responses did 
not change from 0 to 19 dpi. A response was only observed after stimulation with EspB at day 0. 
It is not clear why there was no proliferative response towards the other antigens. Non-
vaccinated animals seemed to respond to the infection at 19 dpi, as indicated by increased SI-
values for intimin, EspA and Tir, although there were no significant differences (p > 0.05). 
Interestingly, shedding levels had dropped substantially by 19 dpi for most animals (Figure 1). 
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3.4.4 E. coli O157:H7-specific ASC in spleen, lymph nodes and intestinal sites 
To investigate the localization of the O157-specific antibody response when the decrease 
in shedding occurred, the number of intimin-, EspA-, EspB- and Tir-specific IgG and IgA ASC were 
determined in the spleen, MLN, CoLN, RLN, JPP, IPP and LPR (Figure 3a). Vaccinated animals had 
intimin- and EspA-specific IgG ASC in the spleen, as a result of the intramuscular immunizations. 
However, IgG responses against EspB and Tir were very low, and were in line with what was seen 
for PBMC at 5 dpi. IgG responses in the draining lymph nodes were low against all four antigens. 
Interestingly, the vaccinated animals had a clear EspA-specific IgG response in the JPP, in 
contrast to the non-vaccinated animals which showed only an EspA-specific IgG response in the 
IPP. In the rectal lamina propria, a very high background for IgG and IgA was observed in the 
control group against all four antigens, making interpretation impossible. IgA ASC were absent or 
present only in very low numbers in the other tissues. 
 
Figure 2: Lymphocyte proliferative responses of PBMC from control and re-infected vaccinated and non-vaccinated 
sheep, following in vitro stimulation with intimin, EspA, EspB and Tir (mean ± SEM). Dpi:days post inoculation. 
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Figure 3: E. coli O157:H7-specific IgG ASC per 5 x 10
6
 cells in various tissues in the control, vaccinated and non-
vaccinated animals isolated at euthanasia (mean ± SEM). MLN: mesenteric lymph node (LN), CoLN: colon LN, RLN: 
rectal LN, JPP: jejunal Peyer’s patches (PP), IPP: ileal PP. 
3.4.5 Evaluation of cytokine responses of in vitro restimulated MC 
To address the role of cytokines in clearance of E. coli O157:H7 infection, we analysed 
IL-4, IL-10, IL-12, IFN-γ and TNF-α production of in vitro restimulated MC from the different 
tissues. IL-4 was not detected in any of the samples. In general, the cytokine secretion patterns 
in the different groups of animals were similar regardless of the antigen that was used for 
stimulation. However, there were clear differences between some of the cytokines. IL-12 and 
IFN-γ secretion was very similar (Figure 4). Both cytokines were produced by spleen and lymph 
node cells in response to all four antigens, but were low to absent following stimulation of PP 
and LPR cells. IL-12 and IFN-γ responses of non-vaccinated animals were significantly higher in 
MLN cells compared to those of vaccinated animals. This was also the case for IL-10 production 
in the MLN. IL-10 and TNF-α were produced by every tested cell type, although secretion by PP 
and LPR cells was generally lower (Figure 5). Interestingly, TNF-α production seems to be 
suppressed in EHEC-infected animals compared to controls, whether they were vaccinated or 
not. 




Figure 4: IFN-γ and IL-12 concentration in the supernatans of in vitro restimulated cells from various tissues 
isolated at euthanasia (mean ± SEM). MLN: mesenteric lymph node, CoLN: colon LN, RLN: rectal LN, JPP: jejunal 
Peyer’s patches, IPP: ileal PP, LPR: rectal lamina propria. * significant difference (p < 0.05) between groups. 




Figure 5: IL-10 and TNF-α concentration in the supernatans of in vitro restimulated cells from various tissues 
isolated at euthanasia (mean ± SEM). MLN: mesenteric lymph node, CoLN: colon LN, RLN: rectal LN, JPP: jejunal 
Peyer’s patches, IPP: ileal PP, LPR: rectal lamina propria. * significant difference (p < 0.05) between groups. 
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3.5  Discussion 
The role of the host immune response during E. coli O157:H7 infection is largely 
unknown. We have previously shown that E. coli O157:H7 evokes antibody and cellular 
responses during experimental infection of sheep. However, these immune responses do not 
protect sheep against re-infection (Vande Walle et al., 2010b). Since excretion of E. coli O157:H7 
eventually declines and disappears after experimental inoculation, the present study was 
designed to gather information about the role of the immune response during clearance of 
infection. Previously infected animals (Atef Yekta et al., 2010) were re-infected and euthanized 
when shedding declined to determine the immune response at that time. Because vaccination 
with proteins of the type III secretion system appears to induce partial protection in cattle and 
sheep (Potter et al., 2004; Atef Yekta et al., 2010), we included hyperimmunized sheep that were 
also re-infected to evaluate the effect of pre-existing responses against intimin, EspA, EspB and 
Tir. The hyperimmunized animals had high serum antibody levels, antigen-specific circulating 
PBMC early after re-infection and a high number of antigen-specific antibody secreting cells in 
the spleen as a result of the systemic immunization. Curiously, proliferative responses were low 
to absent despite a booster immunization one week before the infection. In contrast, the non-
vaccinated animals did not have serum antibodies but reacted to the infection with proliferative 
responses. More differences between the groups of animals were apparent in their cytokine 
responses, with regulatory and Th1 cytokines (IL-12, IFN-γ) being lower in the vaccinated animals 
compared to the non-vaccinated animals. This could indicate suppression of the cell-mediated 
immunity. Differences between vaccinated and non-vaccinated animals were also observed for 
the anti-inflammatory cytokine IL-10. Levels of IL-10 showed the tendency to be higher in spleen, 
mesenteric and rectal lymph nodes of non-vaccinated animals whereas production was lower in 
mesenteric and rectal lymph nodes, and jejunal Peyer’s patches of the vaccinated animals. The 
results could suggest that infection with E. coli O157:H7 suppresses the inflammatory response 
by enhancing IL-10 production. Despite the distinct immune response, vaccination did not result 
in a significant reduction of shedding.  
It is remarkable that re-infected non-vaccinated animals did not respond serologically to 
the infection, whereas this was the case in our previous study (Vande Walle et al., 2010b). 
However, in the latter study, animals were re-infected 66 days after the primary infection, 
whereas the period between the primary infection (Atef Yekta et al., 2010) and the re-infection 
described in the present study was twice as long (132 days). This may indicate that there is no 
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induction of long-lasting memory B-cells against the tested antigens. Nevertheless, IgG-and IgA-
secreting cells recognizing intimin and EspA were observed among circulating PBMC 5 days after 
the re-infection in the present study. Whereas IgG-secreting cells were observed with both non-
vaccinated and vaccinated animals, IgA-secreting cells were only present in non-vaccinated 
animals. This IgA response could be a reflection of what is happening in the intestine at that 
time. Isolating PBMC early after infection could be an interesting way to demonstrate a recent 
infection, as they probably respresent a circulating population of immune cells that were primed 
in the intestine. In the future, this method could be used to monitor PBMC responses during the 
course of infection. 
Rectal and oral inoculation of sheep resulted in a different immune response, with serum 
antibodies only detected after oral inoculation (Vande Walle et al., 2010a; Vande Walle et al., 
2010b). Therefore, we hypothesized that E. coli O157:H7 has to pass the small intestine to 
induce antibody responses. Peyer’s patches are known to be important induction sites of 
immune responses, and indeed, antigen-specific antibody secreting cells were isolated from the 
Peyer’s patches of the re-infected animals. Interestingly, vaccinated animals reacted only in the 
jejunal peyer’s patches, in contrast with a response in the ileal Peyer’s patches of the non-
vaccinated animals. When individual data are considered, we noticed that animal 4906 in the 
non-vaccinated group did not respond in the ileal Peyer’s patches (data not shown). Remarkably, 
this animal showed longer excretion than the others in that group. Moreover, animal 4906 had 
higher IL-10 and IL-12 levels than its group mates. We previously noted such differences 
between long- and short-term shedders (Vande Walle et al., 2010b). However, drawing 
conclusions from single observations is far too premature and these findings will have to be 
further investigated in a larger number of animals. Furthermore, evaluating more cytokines will 
provide a more complete profile of the immune response. 
Very few reports of recurrent E. coli O157:H7 infections in humans have been reported 
(Robson et al., 1993; Siegler et al., 1993). Serum antibodies against LPS and Stx were reported in 
healthy farmers, suggesting acquisition of immunity to E. coli O157:H7 (Evans et al., 2000). 
Experimental C. rodentium infection in mice, a highly appreciated animal model for human E. coli 
O157:H7 disease, induces haemorrhagic colitis but protects mice against secondary challenge 
and results in development of long-lived humoral immune responses to intimin, EspA, EspB and 
Tir (Ghaem-Maghami et al., 2001; Mundy et al., 2005). In contrast, cattle and sheep do not 
develop disease and are susceptible to re-infection, both in experimental models and in natural 
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settings (Sanderson et al., 1999; Naylor et al., 2007; Vande Walle et al., 2010a; Vande Walle et 
al., 2010b). From our previous results and the results presented in this study, we conclude that 
there is no induction of a complete protective immunity against E. coli O157:H7 in these species, 
or that it is not sufficiently long-lasting to prevent subsequent infections. In contrast, it is known 
that intestinal clearance of C. rodentium in mice requires B-cells and IgG, but not secretory IgA 
(Maaser et al., 2004). Our results also indicate the dominance of IgG over IgA responses in E. coli 
O157:H7 infection in sheep, as IgA was barely detected among PBMC’s early after infection or 
among intestinal ASC. IgG1 is prominent within mucosal secretions in sheep and cattle, 
suggesting that this isotype may play an important role in mucosal immunity (McNeilly 2008). 
Nevertheless, mucosal IgA responses have been demonstrated in cattle following E. coli O157:H7 
infection (Bretschneider et al., 2008; Nart et al., 2008a). Still, the present study, however 
preliminary, indicates an important role of mucosal immune responses during E. coli O157:H7 
infection. 
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Introduction 
Since its identification in 1982, E. coli O157:H7 has been the subject of many research 
projects. An important part of the work focused on the development of reliable and sensitive 
detection methods, to diagnose infections, to determine the prevalence and to identify the 
public health risk. Gradually, more information became available regarding the reservoir and the 
transmission routes of infection. Although being the causative agent of serious illnesses and 
even death in humans, E. coli O157:H7 resides apparently quietly in ruminants. Ruminants lack 
the Gb3 receptor on endothelial cells and are therefore not susceptible to the effects of Stx, the 
cause of bloody diarrhoea and HUS in humans. The bacterium colonizes the gastrointestinal tract 
of ruminants and has developed means to persist in animals for long periods of time without 
causing clinical signs. But how is it possible that E. coli O157:H7 can persist without being 
eliminated by the immune system? It has been hypothesized that the bacterium suppresses the 
immune system of the host. However, not much is known regarding the interaction of the 
bacteria with the immune system and therefore the aims of this thesis were to determine the 
immune response against E. coli O157:H7 and to obtain insights in the role of the immune 
system in persistence of E. coli O157:H7 in ruminants. 
E. coli O157:H7 elicits non-protective immune responses 
To study the interaction of E. coli O157:H7 with the immune system of ruminants, we 
developed two sheep infection models. In a first model, sheep were inoculated with E. coli 
O157:H7 via a rectal route (Chapter 1). The choice of this route was based on the identification 
of the terminal rectum as a primary colonization site in cattle (Naylor et al., 2003). Following 
rectal inoculation of cattle, E. coli O157:H7 adhered to the rectal mucosa, leading to persistent 
colonisation and long-term recovery of the bacteria in the faeces (Sheng et al., 2004). In our 
study, rectal inoculation of sheep with a high dose of E. coli O157:H7 led to shedding of the 
bacteria for several weeks and even months in sheep inoculated by a method referred to as the 
2-days-sponge method. The immune system of the host was able to recognize the bacterium, 
reflected by a cellular immune response against intimin, EspA and EspB, three important 
virulence factors of E. coli O157:H7. However, the presence of this response did not prevent 
animals from becoming colonized after a second inoculation. Surprisingly, an antibody response 
could not be demonstrated. Nevertheless, antibodies have been detected in naturally infected 
sheep (Vande Walle et al., unpublished results) and cattle (Cristancho et al., 2008; Vilte et al., 
2008, Joris et al., in preparation). We investigated this discrepancy in a second study where an 
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oral infection model was used, mimicking the natural route of infection (Chapter 2). In that 
study, both cellular and antibody responses were demonstrated which followed the course of 
infection: rising after the inoculation and decreasing as shedding decreased. When animals were 
re-inoculated, responses rose again and the antibody response sustained even when shedding 
had disappeared. However, this response was not protective, as demonstrated by the fact that 
animals could become re-colonized following a second experimental inoculation. This indicated 
that shedding can re-occur as seen in the field, where animals become infected by much lower 
doses and shedding is typically intermittent. Even after several consecutive negative testings, 
shedding can re-occur (Ellis-Iversen et al., 2009). Re-infection could arise from re-ingestion from 
the environment although it is also possible that E. coli O157:H7 is not cleared from the 
gastrointestinal tract, but remains present in very low numbers, too low to be detected even by 
highly sensitive methods, ready to re-colonize the intestine. Moreover, detection of E. coli 
O157:H7 in faecal samples might be an underestimation of its true prevalence. The bacterium 
might reside in a particular intestinal location different from the rectum while temporarily not 
being excreted. This hypothesis is supported by a recent study in naturally infected cattle, where 
E. coli O157:H7 was found throughout the gastrointestinal tract and presence of E. coli O157:H7 
in any intestinal location could not predict the presence in faecal or recto-anal junction samples. 
Interestingly, an almost 100% correlation was found between recovery of E. coli O157:H7 from 
intestinal content and mucosal samples (Keen et al., 2010), indicating mucosal colonization at 
multiple sites. 
While persisting in such low numbers, E. coli O157:H7 might be invisible for the immune 
system. Possibly E. coli O157:H7 can remain in the intestine, seemingly undetectable, until it 
becomes reactivated by environmental changes such as changes in diet, environmental 
temperature, or through ingestion of more E. coli O157:H7 from the environment or 
modifications in the intestinal flora. Such changes could explain the raised prevalence of E. coli 
O157:H7 during the warmer summer months, when animals are moved from the stable to 
pasture. This movement also includes a change in diet and in physiological health status of the 
animals. Encountering more species congeners could trigger the mechanisms of quorum sensing, 
and enhance bacterial replication. When the bacteria are present in sufficient numbers, the 
immune system could become activated, leading to suppression of the bacteria once more. Until 
the next change occurs. This could account for the typically intermittent shedding pattern that is 
observed. An important question is why an individual animal would shed for a longer period of 
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time than another animal of the same breed and age, that has been exposed to the same strain 
and dose in similar experimental conditions. In our studies we identified long and short time 
shedders (Chapter 2 and 3). We hypothesized that the host immune response could play a role. 
Indeed, the data, although preliminary and from a limited number of animals, point to a 
differentially regulated immune response. This should be further investigated. A limitation is the 
accessibility of intestinal tissues, which are generally sampled at euthanasia. We hypothesized 
that interesting information on immune mechanisms could be obtained at cessation of shedding. 
However, the procedures to monitor shedding are time-consuming, the exact moment of 
cessation cannot be predicted and therefore it is difficult to determine a good timing for 
euthanasia. Cannulation of the draining lymph nodes allows to keep the animals alive, and to 
monitor the shedding and immune response throughout the course of infection (Scheerlinck et 
al., 2008). Flow cytometry can be used to identify the type of immune cells involved in this 
response. Before, these studies were hampered by the lack of suitable reagents, whereas 
recently many efforts have been made to develop ovine markers (Entrican et al., 2009).  
Cytokines modulate immune cell functions and exert important roles during infection 
(Scheerlinck and Yen, 2005). In this thesis, we studied the production of different classes of 
cytokines (Chapter 3). and IL-4 represent Th1 and Th2 cytokines, respectively. TNF-α is a pro-
inflammatory cytokine, whereas IL-10 is considered anti-inflammatory and needed to 
downregulate IFN-γ production. IL-12 on the other hand, stimulates IFN-γ production. We have 
observed differences in cytokine production between vaccinated and non-vaccinated animals, 
with indications that E. coli O157:H7 suppresses the cell-mediated immunity. However, we 
should be careful to draw conclusions from this preliminary study. Studying more cytokines 
could provide a more complete profile of the immune response. A subclass of immune cells 
worth investigating are the Th17 cells. They have recently been identified as a new class of CD4+ 
helper T-cells in addition to Th1, Th2, Th3 and Treg cells and are characterised by the production 
of IL-17. Th17 cells play an important role in the defence against extracellular pathogens, 
particularly Gram negative bacteria that colonize mucosal surfaces (Peck and Mellins, 2010). 
Furthermore, they have been implicated in C. rodentium infection. Infection with C. rodentium in 
mice did not strongly influence the expression of Th1 or Th2 cytokines, but affected the 
expression of Th17 cytokines, with significant upregulation of IL-17 and IL-6 at the peak of 
infection (8-10 dpi) and during clearance (21 dpi) (Symonds et al., 2009). IL-22, another cytokine 
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produced by Th17 cells, is required for the early host defense against C. rodentium (Zheng et al., 
2008). Th17 responses to EHEC infection have not been investigated to date. 
Mucosal immunity 
One of the most important findings of this thesis was the difference in gastrointestinal 
localization of E. coli O157:H7 following experimental infection, and the implication of this 
localization for the presence of immune responses. The bacteria were found exclusively in the 
lower gastrointestinal tract of sheep inoculated rectally (Chapter 1), whereas oral inoculation led 
to recovery of E. coli O157:H7 from sites throughout the entire digestive tract (Chapter 2). In 
addition, the observation that serum antibody responses were only detected after oral 
inoculation but not after rectal inoculation, suggests that E. coli O157:H7 has to pass the small 
intestine to evoke antibody responses. Cellular responses were present after both rectal and oral 
inoculation, indicating that these responses can be initiated in the lower gastrointestinal tract. 
The ovine rectal mucosa is known to contain lymphoid follicles, similar to Peyer’s patches in the 
small intestine which are induction sites of immune responses (Sedgmen et al., 2002).  Indeed, 
antigen-specific antibody-secreting cells were detected in the rectal lamina propria (Chapter 2). 
This response was the strongest in an animal that had very recently stopped shedding, whereas 
it was virtually absent in another animal that ceased shedding almost 6 weeks earlier. In addition 
to the response found in the rectal lamina propria, antigen-specific antibody secreting cells were 
found in the jejunal and ileal Peyer’s patches of re-infected animals (Chapter 3). Interestingly, 
such a response was not detected in one animal which was still shedding at the time of 
euthanasia and was excreting for a longer period of time than the other animals in its group. 
These findings indicate that mucosal immune responses are important during E. coli O157:H7 
infection, but mucosal protection is possibly limited in space and time. 
Why are the immune responses not protective? 
Although all vaccination protocols tested to date rendered serum antibodies and even 
mucosal antibodies against the target proteins, some were ineffective and none were able to 
completely reduce faecal shedding of E. coli O157:H7 (Potter et al., 2004; McNeilly et al., 2008; 
Thornton et al., 2009). Generally a reduction in the amount of shed bacteria was achieved, or 
vaccinated cattle were less likely to shed E. coli O157:H7 than non-vaccinated cattle (Peterson et 
al., 2007b; Thornton et al., 2009). However, even when fewer cattle were shedding, the ones 
that did, continued to shed in high amounts (McNeilly et al., 2008).  
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 Increasing amounts of evidence point to an immunomodulatory effect of EHEC. Early 
inflammatory responses are present, even before colonisation has been established, but do not 
offer protection against infection. It is likely that the inflammatory response is dampened by 
EHEC effectors. For instance, EHEC negatively modulates host signalling cascades like the IFN-γ-
mediated signal transduction pathway (Ceponis et al., 2003; Jandu et al., 2007). In our studies it 
was clear that EHEC infection induces immune responses that are not protective. Moreover we 
did not see signs of suppression as cellular responses were still present and lymphocytes 
responded well to mitogen stimulation with ConA (unpublished results). Recently, an 
immunomodulatory role of the related pathogen EPEC has been shown, whereby the wild type 
strain induced massive influx of neutrophils and macrophages and secretion of proinflammatory 
cytokines in the ileum of orally inoculated rabbits without recruitment of T-cells or T-cell induced 
cytokines. A tir/espB deletion mutant did not exert these effects, demonstrating the role of 
injected effector molecules (LeFoll et al., 2010). To confirm these results for EHEC infection in 
sheep, the infiltration of immune cells in different tissues should be investigated, preferably at 
different time points after infection. 
E. coli O157:H7: an invincible pathogen? 
E. coli O157:H7 gains its strength from 1) its great survival capacity to enter the saliva 
barrier in the oral cavity and resist the acidic environment of the stomach, thereby entering the 
small and finally the large intestine, 2) its remarkable adhesion mechanism, resulting in a strong 
intimate adhesion to the host cell, 3) its ability to withstand host immune responses. During 
evolution, E. coli O157:H7 has acquired several virulence factors enabling these mechanisms, 
each time gaining in virulence capacity. By means of its effector molecules, it seems that EHEC 
can counteract every possible attack of the host. Increased mucus secretion to flush away 
loosely adherent bacteria is tackled by the action of the mucinase StcE (Grys et al., 2006; 
Bergstrom et al., 2010), whereas Cif blocks the cell cycle of infected epithelial cells, thereby 
preventing cell death and subsequent elimination of the pathogen. Although the development of 
immune responses is not arrested as shown in this thesis, the action of immune cells is 
countered by lymphostatin, which blocks the proliferation of lymphocytes (Abu-Median et al., 
2006). Furthermore, the innate immunity is subverted by resisting the complement pathway 
through the effects of Stx2, StcE and EspP (Lathem et al., 2004; Orth et al., 2009; Orth et al., 
2010). EspP has recently been shown to specifically cleave C3b and C5 of the complement 
pathway (Orth et al., 2010). This finding may explain how E. coli O157:H7 can resist the antibody 
General discussion and future perspectives 
98 
response. The complement pathways are activated by antigen-antibody complexes and other 
structures on the pathogen surface and lead to phagocyte recruitment, opsonisation and lysis by 
the membrane attack complex. C3b and C5 are involved in many of these processes, and are 
rendered inactive by EspP. Furthermore, the action of the recently discovered subtilase 
cytotoxin cleaves secreted antibodies (Hu et al., 2009). In the light of these recent findings, it 
becomes more and more clear that E. coli O157:H7 does not inhibit the early development of 
immune responses. However, the pathogen has acquired multiple ways to resist the effector 
functions of the immune response, allowing E. coli O157:H7 to persist in the presence of an 
adaptive immune response. Thus, EHEC can multiply and colonize for a long time. The factors 
leading to its ultimate removal are yet unknown. 
Role of Shiga toxin in infection 
Immune responses to intimin, EspA, EspB and in the third study also Tir were examined in 
this thesis. All four molecules are important colonization factors, mediating adherence of E. coli 
O157:H7 to the epithelium. Data from experimental studies have shown that intimin and Tir are 
necessary for persistence (Sheng et al., 2006b). Nevertheless, other molecules like H7 or OmpA 
play a role in the adhesion and pathogenesis and are worth to be studied. In the first place, the 
influence of Shiga toxin on immune responses should be investigated. We used a Shiga toxin-
negative strain, which was used before in several in vitro and in vivo infection models and can 
persist in sheep (Dibb-Fuller et al., 2001; Wales et al., 2002; Woodward et al., 2003, our studies). 
The role of Stx in colonisation is unclear. In cattle, Shiga toxins are likely degraded before they 
can influence the immune response (Hoey et al., 2003) and they are also not involved in E. coli 
O157:H7 colonisation of the lymphoid follicle-associated epithelium in the terminal rectum 
(Sheng et al., 2006b). It was reported that Stx2 does not play a role in the colonization of E. coli 
O157:H7 in sheep (Cornick et al., 2007), whereas it enhanced adhesion of E. coli O157:H7 to 
cattle intestinal tissue explants (Lowe et al., 2009). However, whereas the first study used 
isogenic strains to investigate the role of Stx, the latter study determined colonization of strains 
of different lineages. Enhanced colonization of Stx2-positive E. coli O157:H7 compared to the 
isogenic deletion mutant in mice was attributed to increased in vitro expression of nucleolin by 
Stx2 (Robinson et al., 2006), although the significance of this receptor in colonization is unclear 
(Sinclair et al., 2006). In vitro studies have demonstrated that Stx is capable of suppressing the 
proliferation of bovine lymphocytes. The influence of Stx on development of immune responses 
against other virulence factors should be looked into. Experimental infections with Stx positive 
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strains require specialized animal facilities and should be carefully conducted to avoid human 
infections and spread of the strain into the environment. 
Differences between human and ruminant hosts 
E. coli O157:H7 is generally regarded as a harmless bacterium in cattle. Nevertheless, 
Baines et al. (2008) identified mucosal haemorrhages in experimentally inoculated cattle and 
stated that the bacterium is in fact a ruminant pathogen. Since long a differentially regulated 
effect of E. coli O157:H7 on human and bovine cells has been suspected, but it should be 
formally investigated whether this is the case. It has been shown that ruminants are not 
susceptible to Stx-induced disease, but this does not mean they are not affected by other 
pathogenic mechanisms. To investigate the difference between human and ruminant infection, 
it would be interesting to further study cellular responses, e.g. by studying the effect of in vitro 
stimulation with E. coli O157:H7 proteins on human, bovine and ovine lymphocyte proliferation 
and cytokine production. 
The evidence supporting the hypothesis of immune suppression in ruminants is mainly 
derived from in vitro experiments, whereas monitoring the full course of an immune response in 
humans as can be done in ruminant experimental infection models is impossible due to obvious 
ethical objections. Immune responses against different E. coli O157:H7 molecules, such as 
intimin, EspA, EspB, LPS, H7 and Stx have been identified in both humans and ruminants. 
Nevertheless, the full repertoire of immunogenic determinants of E. coli O157:H7 is not known. 
A better knowledge of these antigens might be crucial in understanding the difference between 
the human and ruminant host and may aid in designing an effective control measure for the 
spread of E. coli O157:H7. Approaches such as protein micro-arrays have been successful in 
identifying antigens that are differentially recognized between humans and animal reservoir 
hosts of the zoonotic pathogen Brucella melitensis (Liang et al., 2010). 
Theories in the margin 
E. coli O157:H7 persists inside the ruminant reservoir host apparently without causing 
harm and is spread into the environment, from where it is eventually transmitted to humans. It 
was shown that this is not a merely commensal relationship: E. coli O157:H7 causes a certain 
amount of damage to the ruminant’s intestinal tract in the form of focal mucosal haemorrhages 
associated with E. coli O157:H7 colonisation sites (Baines et al., 2008). Then what is the 
advantage for the ruminant to harbour these bacteria? A possible explanation is that the 
General discussion and future perspectives 
100 
presence of STEC renders cattle and sheep less susceptible to viruses, such as bovine leukemia 
virus, bovine immunodeficiency virus and equine infectious anaemia virus. Animals that carried 
high numbers of STEC remained in good health, whereas low numbers were correlated with a 
poor prognosis in sheep infected with bovine leukemia virus (Ferens et al., 2008). Possibly STEC 
influences IFN-γ en IL-12-dependent pathways, which are correlated with resistance to bovine 
leukemia virus (Kabeya et al., 2001). As with E. coli O157:H7, many parasitic infections such as 
Cooperia in calves result in distinct shedding patterns (Kanobana et al., 2003). Animals can be 
classified into low, intermediate and high responders, correlated to the speed by which worms 
are expelled from the host due to an immune response (van Diemen et al., 1997; Kanobana et 
al., 2001). IgE is known to play a role in immunity against parasitic infections, so it could be 
worthwhile to investigate the role of IgE in E. coli O157:H7 infections in ruminants. 
Many pathogenic micro-organisms that cause chronic infections undergo mutations to 
withstand the immune system, the best example being the human immunodeficiency virus 
which continuously changes its virulence determinants. In particular, outer-membrane 
determinants are changed under immunological pressure. E. coli O157:H7 is prone to 
evolutionary changes, as evidenced by its origination from an EPEC O55 strain, by acquisition of 
the Shiga toxin and other virulence genes through horizontal transfer. Variants have been 
identified in important colonization factors such as intimin, EspA, EspB, Tir and smaller 
nucleotide differences between strains have been demonstrated. Moreover, certain strains are 
associated with elevated virulence (Laing et al., 2009), making it likely that a single E. coli 
O157:H7 strain can evolve and adapts itself to the environment, possibly under the pressure of 
the host’s immune system. Usually different strains isolated from different sources are 
investigated, but to our knowledge the evolution of a single strain in time has not been 
investigated yet. A limited number of pulsed-field gel elektrophoresis (PFGE)-profiles could be 
identified among different strains isolated from farm animals, indicating low sequence diversity 
(Vali et al., 2005). Interestingly, there was a change in PFGE and phage types from isolates shed 
by cattle at pasture compared with those shed by the same cattle when weaned and housed in 
pens. In contrast, characterizations of E. coli O157:H7 isolates from Belgian farm cattle using 
PFGE, revealed that on each positive farm only one genotype was present, even after a period of 
more than six months (Cobbaut et al., 2008), suggesting there is very little selective pressure on 
E. coli O157:H7. More detailed investigations have shown positive selection pressure on rhs 
genes, which encode extracellular proteins that are possibly involved in promotion of survival of 
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E. coli O157:H7 during the intestinal transit (Liu et al., 2009), and a short segment in the central 
region of the fliC gene encoding flagellin has been under positive selection in the divergence of 
H6 and H7 alleles (Reid et al., 1999). Perhaps a far-fetched hypothesis, but positive selection 
might pose a mechanism for E. coli O157:H7 to resist the ruminant host’s immune system. 
Future perspectives 
Despite the expanding knowledge regarding the colonization mechanisms of E. coli 
O157:H7, the research regarding the immune response to this pathogen is still in its infancy. The 
issues discussed above have highlighted important questions that should be addressed. Future 
work should focus on elucidating the role of Stx on the immune response, by comparing 
responses to Stx-negative and -positive strains. Simultaneously, efforts should be made to 
address the role of other antigens, to unravel the impact and the importance of these antigens 
during infection. This thesis and other research focused on intimin, EspA, EspB and Tir, key 
virulence factors during colonisation, however, it remains uncertain which antigens are defining 
the immune response to E. coli O157:H7. Techniques such as protein micro-arrays would be very 
helpful to identify immunogenic antigens and differences in immune responses between natural 
and carrier hosts, or between infected and non-infected animals (Liang et al., 2010). 
Furthermore, the immune cells taking part in the immune response should be identified. 
Cannulation and flow cytometry experiments are excellent ways to characterize the cell 
populations which determine the outcome of infection (Scheerlinck et al., 2008; Entrican et al., 
2009). Finally, monitoring immune responses at different time points during infection will 
provide valuable information regarding infection kinetics, and may aid to answer the question 
why individual animals are prone to long-term shedding whereas others are not. This knowledge 
can be implemented in the design of efficient vaccines against E. coli O157:H7. 
 
In conclusion, knowledge regarding the pathogenesis and persistence of EHEC and in 
particular serotype E. coli O157:H7 in ruminants still has many frontiers. Many in vitro data 
should be confirmed in vivo. Until a good vaccination strategy is found, hygienic measurements 
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Enterohaemorraghic E. coli (EHEC) form a subgroup of Shiga-toxin producing E. coli 
serotypes closely associated with haemorraghic colitis (bloody diarrhoea) and the haemolytic 
uremic syndrome in man. Most cases are caused by infection with E. coli O157:H7. E. coli 
O157:H7 colonizes the gastrointestinal tract of ruminants and is excreted in the faeces. 
Ruminants constitute the major reservoir, spreading the infection to humans by a faecal-oral 
route. The animals do not suffer from infection as they lack the receptor for Shiga toxin in the 
intestinal epithelium. During slaughter the bacteria can be transferred to the carcass, posing a 
risk for foodborne infection when the meat is insufficiently heated prior to consumption. Other 
products at risk to become contaminated with E. coli O157:H7 are raw milk, cheese and 
vegetable crops. Consumption of EHEC-contamined food poses an important public health risk 
and has important economic consequences. 
E. coli O157:H7 uses a type III secretion system to establish close contact with the host 
cell. Important colonization factors are intimin, EspA, EspB and Tir. Following adhesion, several 
effector molecules are injected into the host cell, which subvert the normal cellular processes. 
Although a great deal is already known regarding the colonization mechanisms of this pathogen 
in the intestine, it remains to be elucidated how and why E. coli O157:H7 can be persistently 
present in ruminants. It has been hypothesized that the immune system of the host is 
suppressed. To date, only limited information is available regarding the interaction of E. coli 
O157:H7 with the immune system of ruminants. The study of this interaction can contribute to a 
better understanding of the persistence of E. coli O157:H7 and may have applications in the 
reduction of the spread of these bacteria.  
Part I of this thesis provides an overview of the literature. The pathogenesis in humans 
and the principal characteristics of the animal reservoir are described, as well as the current 
control and reduction strategies. Subsequently, the virulence factors of  E. coli O157:H7 are 
discussed, followed by the effector molecules known to date. Finally, the immune response of 
humans and cattle against this bacterium is described.  
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Knowledge regarding the immune response of sheep is non-existent so far and therefore 
the general aim of this thesis was to gain insight in the interaction of E. coli O157:H7 with the 
immune system of sheep. Following questions were addressed in the experimental work of this 
thesis: 
Does experimental infection, by a rectal or an oral route, lead to persistent colonization? 
Does infection result in an immune response and does this protect against re-infection? 
What is the role of this immune response in clearance of the infection in sheep? 
 
To investigate the effects of colonization on the immune system of sheep, an infection 
model is needed that mimics a long-term infection as it can occur in both sheep and cattle. Since 
the terminal rectum has been identified as a primary colonization site in cattle, a rectal 
inoculation model was developed in the first study (Chapter 1). Rectal application of a sponge, 
containing 1010 CFU E. coli O157:H7, administered on 2 consecutive days, resulted in shedding 
that endured 48 to 78 days. This method was used to analyse the immune response of infected 
sheep against virulence factors of E. coli O157:H7. The primary infection did not lead to a 
protective immune response, as demonstrated by the fact that the sheep became recolonized 
after the administration of a secondary inoculation. Although a cellular response occurred 
against intimin, EspA and EspB, surprisingly a serum antibody response was absent. Colonization 
of E. coli O157:H7 extended from the rectum to the distal large intestine, in contrast to the 
restricted colonization of the recto-anal junction observed in cattle. 
Since serum antibodies are found in naturally infected sheep that most likely have 
ingested the bacteria, an oral infection model was used to infect sheep with E. coli O157:H7 in 
the second study (Chapter 2). A primary oral inoculation resulted in shedding of E. coli O157:H7 
in the faeces and detection of antibody responses against intimin, EspA and EspB. The antibody 
titres waned as shedding decreased. A secondary inoculation resulted in longer shedding, even 
though a booster antibody response occurred. Cellular responses followed a similar pattern as 
the antibody levels, although the cellular secondary response was lower. The presence of 
antigen-specific antibody-secreting cells indicates involvement of both a systemic response in 
the spleen and a local immune response in the terminal rectum. Combined with the results from 
the rectal inoculation study, these results imply that E. coli O157:H7 has to pass the small 




Shedding of E. coli O157:H7 by ruminants can last for weeks, even months, but eventually 
the infection ceases. To determine the role of the immune response in clearance of E. coli 
O157:H7, the third study was designed (Chapter 3). Previously infected animals were re-infected 
with E. coli O157:H7 and euthanized when excretion decreased to analyse systemic and local 
immune responses to intimin, EspA, EspB and Tir. In addition, we investigated the influence of 
preceding immunization with these antigens. ELISPOT tests revealed mucosal antibody 
responses against EspA, in the jejunal Peyer’s patches of vaccinated animals and in the ileal 
Peyer’s patches of non-vaccinated animals. Cytokines IL-12 and IFN-γ were produced by 
mesenteric lymph node cells, whereas IL-10 and TNF-α were also produced by intestinal 
lymphocytes. Individual differences between longer and shorter shedding animals were 
observed, indicating the importance of mucosal immune responses during E. coli O157:H7 
infection. However, E. coli O157:H7 infection does not seem to result in the induction of long-
lasting memory cells, and mucosal protection might be limited in space and time. 
 
The final part of this thesis contains the general discussion and main conclusions of this 
work. The experiments show that E. coli O157:H7 can colonize sheep for a long period of time. 
Passage through the small intestine appears to be important for the initiation of immune 
responses, as serum antibodies were only observed following oral and not following rectal 
inoculation. However, cellular responses were present in both cases. Although it was shown that 
cytokine responses occur when the infection pressure diminishes, the role of the immune 
system in clearance of the infection remains unclear. Further research is needed to elucidate the 








Enterohaemorraghische E. coli (EHEC) omvat een subgroep van Shiga-toxine 
producerende E. coli serotypes die nauw geassocieerd worden met haemorraghische colitis 
(bloederige diarree) en het haemolytisch uremisch syndroom bij de mens. De meeste gevallen 
worden veroorzaakt door infectie met E. coli O157:H7. E. coli O157:H7 koloniseert de darm van 
herkauwers en wordt uitgescheiden in de faeces. Herkauwers vormen het voornaamste 
reservoir, waarbij de infectie naar de mens verspreid wordt via een faeco-orale route. De dieren 
ondervinden zelf geen klinische gevolgen van de infectie omdat ze de receptor voor het Shiga 
toxine missen op het darmepitheel. Tijdens het slachtproces kan de bacterie op de karkassen 
terecht komen, wat kan leiden tot een voedselinfectie wanneer het vlees niet voldoende verhit 
wordt vóór consumptie. Andere risicoproducten zijn producten die mogelijks in contact zijn 
gekomen met besmette faeces zoals rauwe melk, kaas en groenten. Consumptie van met EHEC 
besmette voedingswaren vormt een belangrijk gezondheidsrisico voor de mens en heeft 
bovendien belangrijke economische gevolgen. 
E. coli O157:H7 gebruikt een type III secretiesysteem om nauw contact te maken met de 
gastheercel. Belangrijke eiwitten in dit proces zijn intimine, EspA, EspB en Tir. Na adhesie 
worden verscheidene effectormoleculen in de gastheercel geïnjecteerd, die de normale 
processen in de cel verstoren. Hoewel reeds veel geweten is over de manier waarop deze 
pathogeen de darmen koloniseert, moet nog opgehelderd worden hoe en waarom E. coli 
O157:H7 persistent aanwezig kan blijven bij herkauwers. Mogelijks speelt een onderdrukking van 
het immuunsysteem van de gastheer een rol. Tot nu toe is er slechts beperkte informatie over 
de interactie van E. coli O157:H7 met het immuunsysteem van herkauwers. Het bestuderen van 
deze interactie kan bijdragen tot het begrijpen van de persistentie van E. coli O157:H7 en 
toepassing hebben in het reduceren van de verspreiding van deze bacterie. 
 
Deel I van deze thesis geeft een overzicht van de literatuur. De pathogenese bij de mens 
en de voornaamste kenmerken van het herkauwer reservoir worden weergegeven, evenals een 
actueel overzicht van mogelijke bestrijdings- en inperkingsmiddelen. Vervolgens komen de 
virulentiefactoren van E. coli O157:H7 aan bod, evenals de tot nu toe gekende 




Over de immuunrespons van schapen is echter tot nu toe niets geweten en het algemene 
doel van deze thesis was dan ook inzicht te krijgen in de interactie van E. coli O157:H7 met het 
immuunsysteem van schapen. Hoofdstukken 1 tot 3 geven het experimenteel werk van deze 
thesis weer. Daarbij werd een antwoord gezocht op volgende vragen: 
Leidt experimentele infectie van schapen, hetzij via een rectale route, hetzij via een orale 
weg, tot een persistente kolonisatie? 
Wordt er een immuunrespons opgebouwd en beschermt deze tegen herinfectie? 
Wat is de rol van deze immuunrespons tijdens het verdwijnen van de infectie bij 
schapen? 
 
Om het effect van kolonisatie op het immuunsysteem van schapen te bestuderen, is een 
infectiemodel nodig dat de langdurige infectie zoals die kan voorkomen bij schapen en runderen 
nabootst. Aangezien het terminale rectum werd geïdentificeerd als een primaire 
kolonisatieplaats bij het rund, werd een rectaal infectiemodel ontwikkeld in de eerste studie 
(Hoofdstuk 1). Rectaal aanbrengen van een spons die 1010 bacteriën bevatte, en dit op 2 
opeenvolgende dagen, gaf een uitscheiding die 48 tot 78 dagen aanhield. Deze methode werd 
gebruikt om de immuunrespons van geïnfecteerde schapen tegen virulentiefactoren van E. coli 
O157:H7 te analyseren. De primaire infectie leidde niet tot opbouw van een beschermende 
immuunrespons, wat bleek uit het feit dat de schapen opnieuw konden gekoloniseerd worden 
na toedienen van een secundaire inoculatie. Hoewel er een cellulaire immuunrespons optrad 
tegen intimine, EspA en EspB, was een serum antistoffenrespons verrassend genoeg afwezig. E. 
coli O157:H7 koloniseerde de darm van het rectum tot de distale dikke darm, in tegenstelling tot 
de beperktere kolonisatie van de recto-anale junctie bij het rund. 
Omdat serum antistoffen aangetroffen worden bij natuurlijk geïnfecteerde schapen, die 
hoogstwaarschijnlijk de bacterie via de mond hebben opgenomen, werd in de tweede studie een 
oraal infectiemodel gebruikt om schapen te infecteren met E. coli O157:H7 (Hoofdstuk 2). Een 
primaire orale inoculatie resulteerde in uitscheiding van E. coli O157:H7 in de faeces en detectie 
van antistoffen tegen intimine, EspA en EspB. De antistoffentiters verdwenen wanneer de 
uitscheiding verminderde. Een secundaire inoculatie leidde tot een langere uitscheiding, zelfs in 
de aanwezigheid van een booster antistoffenrespons. Cellulaire responsen volgden een 
gelijkaardig patroon als de antistoffen, hoewel de secundaire cellulaire respons lager was. De 
detectie van antigeen-specifieke antistofsecreterende cellen duidt op een systemische respons 
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in de milt en een lokale immuunrespons in het terminale rectum. Gecombineerd met de 
resultaten van de rectale inoculatiestudie suggereren deze bevindingen dat E. coli O157:H7 de 
dunne darm moet passeren om een antistoffenrespons op te wekken. Toch beschermen deze 
antistoffen niet tegen herinfectie. 
Uitscheiding van E. coli O157:H7 door herkauwers kan weken, zelfs maanden aanhouden, 
maar stopt uiteindelijk. De derde studie werd opgezet om de rol van de immuunrespons tijdens 
het verdwijnen van de infectie te bepalen (Hoofdstuk 3). Eerder geïnfecteerde dieren werden 
geherinfecteerd met E. coli O157:H7 en geëuthanazeerd wanneer de uitscheiding daalde om de 
systemische en lokale immuunrespons tegen intimine, EspA, EspB en Tir te bestuderen. 
Daarnaast werd de invloed van voorafgaande immunisatie met deze antigenen nagegaan. 
ELISPOT testen detecteerden een mucosale antistoffenrespons tegen EspA, in de jejunale 
Peyerse platen van gevaccineerde dieren en in de ileale Peyerse platen van niet-gevaccineerde 
dieren. IL-12 en IFN-γ werden geproduceerd door cellen van mesenteriale lymfeknopen, terwijl 
IL-10 en TNF-α ook geproduceerd werden door intestinale lymfocyten. Er werden individuele 
verschillen tussen langer en korter uitscheidende dieren waargenomen, wat het belang van 
mucosale immuunresponsen tijdens E. coli O157:H7 aanduidt. Nochtans lijkt infectie met E. coli 
O157:H7 niet te resulteren in de inductie van langlevende geheugencellen, en is mucosale 
bescherming vermoedelijk beperkt in plaats en tijd. 
 
Het laatste deel van deze thesis bevat de algemene discussie en de belangrijkste 
conclusies van dit werk. De experimenten tonen aan dat E. coli O157:H7 schapen kan 
koloniseren op een langdurige manier. Passage door de dunne darm lijkt belangrijk te zijn voor 
het opwekken van immuunresponsen, daar serum antistoffen enkel gezien werden na orale 
inoculatie en niet na rectale inoculatie. Cellulaire responsen waren echter in beide gevallen 
aanwezig. Hoewel werd aangetoond dat cytokineresponsen optreden op het moment dat de 
infectiedruk lager wordt, blijft het onduidelijk welke immuunmechanismen betrokken zijn in het 
verdwijnen van de infectie. Verder onderzoek is noodzakelijk om de mechanismen die zorgen 
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Hier is het dan, de synthese van het werk van de afgelopen jaren, de kers op de taart. Dit 
boekje kan onmogelijk omvatten hoe intensief deze doctoraatsperiode is geweest, wat er 
allemaal kwam bij kijken, of welke emoties ermee gepaard gingen. Nu ben ik klaar voor een 
nieuwe uitdaging, maar ik kijk met plezier terug op de voorbije jaren en wil graag een aantal 
mensen in de bloemetjes zetten, die me uitgebreid geholpen en gesteund hebben.  
 
Waar beter te beginnen dan bij mijn promotor, Prof. Eric Cox. In 2005 kreeg u een 
studente over de vloer die amper een varken of een schaap van dichtbij had gezien, maar u zag 
het wetenschappelijk potentieel en gaf me de kans een doctoraat te beginnen aan het Labo voor 
Immunologie. Hoewel ik nog steeds niet begrijp hoe u zo ontspannen tegen deadlines kan 
aanwerken, moet ik het u nageven: het is altijd in orde gekomen! Bedankt voor uw kritische 
opmerkingen  en de stimulansen om goede resultaten af te leveren. Ik heb bijzonder veel 
geleerd van de wetenschappelijke discussies en van onze samenwerking. Ook mijn mede-
promotor, Prof. Daisy Vanrompay, ben ik dankbaar voor de hulp bij de interpretatie van de 
resultaten.  
Een belangrijk woord van dank gaat uit naar Frank Verdonck. Je was mijn begeleider 
gedurende de eerste twee jaar van het doctoraat en ik mag wel zeggen dat je me goed op weg 
hebt gezet. Je maakte steeds tijd vrij voor al mijn vragen. Ik vind het bijzonder fijn dat je nu als 
jurylid toch de afwerking van dit werk kan meemaken!  
Ook Prof. Lieven De Zutter heeft een belangrijke rol gespeeld bij het tot stand komen van 
dit werk. Ik mocht mijn bacteriologisch werk uitvoeren in uw labo en leerde daarbij veel over de 
niet-immunologische kant van E. coli O157:H7.  Bedankt voor uw interesse en betrokkenheid. 
Bedankt aan de overige leden van de lees- en examencommissie (Prof. F. Haesebrouck, 
Dr. M. Heyndrickx, Prof. J. Mainil, Prof. M. Uyttendaele) voor de tijd en moeite die ze namen om 
constructieve opmerkingen te leveren op dit werk. Dit geldt eveneens voor alle leden van het 
FOD begeleidingscomité voor hun inspanningen tijdens de jaarlijkse vergaderingen. 
 
Aan alle vroegere en huidige Immunootjes: BEDANKT! Voor alle hulp bij de slachtingen, 
beantwoorden van vragen, de steun en de gezellige sfeer binnen en buiten de werkuren.  
Maryam, my “partner in crime”, it was a wonderful experience working on the EHEC 
project with you. Together we explored the amazing world of E. coli O157:H7, learned how to 
handle the sheep, mastered this subject but most of all we shared the emotional rollercoaster of 
making a PhD. I wish you all the best with finishing your work! And I am sure that some day you 
will find a warm and safe place in the world to “settle down and make babies”. 
Mijn burogenootjes, Edith, Eva, Philippe en Tine, jullie maakten de laatste fase van mijn 
doctoraat van heel dichtbij mee. Edith, de ervaring van jou en Bert als kersverse doctorandi was 
zeer waardevol tijdens mijn eigen voorbereidingen! Geen vraag of moeite was je te veel. Ook 
buiten het werk konden we het goed met elkaar vinden toen we het zwembad van Merelbeke 
onveilig maakten met onze bolle buiken! Eva, ook met jou had ik plezante babbels over vanalles 
en nog wat. Met jouw scherpe kritische geest ben ik er zeker van dat je binnenkort een mooi 
werk gaat afleveren. Veel succes! Tine, jij kon dikwijls zorgen voor een levendige noot in de 
buro! Veel succes nog met de knorries en de bouwplannen. Philippe, wat er ook beweerd wordt, 
je stond je mannetje tussen al die vrouwen! Je  bent immer behulpzaam en ik ben ervan 
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overtuigd dat je harde werk binnenkort ook mooie resultaten zal opleveren. Maar zou je toch 
niet eens een nieuwe computer kopen? 
 Vesna, Annelies, Michaela, Edith en Bert, met jullie is er ondertussen een mooie groep 
post-docs gevormd, hopelijk kunnen jullie je kennisdomein uitbreiden met een zwerm 
doctoraatsstudenten onder jullie vleugels. Bert, ’s morgens ben je soms een brombeer maar dan 
toch één die dikwijls voor hilariteit zorgde tijdens de middagpauzes! Annelies, bedankt voor de 
fijne samenwerking op het Veos-project. Michaela, bedankt voor je hulp met raad en daad, je 
bent een waardevolle aanwinst voor ons labo! Vesna, jij moet zowat de “ancien” van ons labo 
zijn, veel succes nog met alles wat je onderneemt!  
Gosia, Delfien, Marina, Pedro, Ut, Bakr en Kim, allemaal in verschillende stadia van het 
doctoraatsonderzoek. Veel succes nog! My foreign colleagues, I enjoyed learning about your 
cultures, however strange they sometimes may seem. But I am sure you feel the same way 
about many of the Belgian habits! Marina, it was nice to have you in our lab. Gosia, proficiat met 
je aanstelling als assistent, je gaat dat goed doen! Delfien, veel succes met de schaapjes, probeer 
ze in leven te houden he. 
Denise, Rudy, Griet, Maaike, Simon, Pieter, Ann en Sarah: bedankt voor alle hulp met 
grote en kleine dingen! Denise, jij was en bent nog steeds van onschatbare waarde voor het 
labo. Rudy, bedankt voor alle hulp met de schapen en zoveel meer. Laat eens weten hoe oud het 
labo-lammetje geworden is! Griet, ook een vaste waarde, bedankt voor de hulp in het labo, 
zeker toen ik zwanger was. Maaike, qua opruim- en organisatietalent ben je ongeëvenaard! 
Simon, voorzichtig met die knie en denk aan de Cola light-man wanneer je de was wegbrengt! 
Pieter, bedankt voor “de perfecte gels”! Ann, bedankt voor het in orde brengen van bestellingen 
en dergelijke meer. Sarah, met jou heeft de ploeg er een sterke kracht bij! 
Herman, Céline, Nina, Thary, Maria, Natasha, Korneel, Cliff, het was fijn het derde verdiep 
met jullie te mogen delen! Beetje bij beetje ontstaat er een echte vermenging van de labo’s en 
dat kan alleen maar goed zijn. 
Enkele personen bevinden zich iets verder weg maar zijn daarom niet minder waardevol: 
Mieke, bedankt voor alle administratie en organisatie! Dirk, wat zou de vakgroep zijn zonder jou 
als computer-expert, merci voor alle hulp. Gert, bedankt voor de goede opvolging van de 
boekhouding! Parasitologen, we hebben de scheiding van verdiep goed doorstaan maar jullie 
fijne gezelschap van vroeger is niet vergeten. 
Ook buiten de vakgroep heb ik veel steun mogen ontvangen. Een grote dankuwel voor 
alle mensen van het labo van prof. De Zutter, voor de fijne babbels en hulp tijdens de verwerking 
van mijn stalen. Dank in het bijzonder aan Martine, Carine en Sandra. Adelheid, ik vond het zeer 
aangenaam om mijn kennis aan jou te mogen doorgeven (en omgekeerd) en samen op congres 
te gaan. Veel succes nog met je doctoraat en geniet van je gezinnetje, maar dat zal wel geen 
probleem zijn! 
Bedankt aan Prof. Van den Broeck en zijn medewerkers voor de hulp bij het verwerken 
van de weefselstalen. De resultaten hebben helaas dit doctoraat niet gehaald, maar ook dat is 
wetenschap. 
Bij een doctoraat hoort ook een mooi boekje met een mooie cover. Jonas en Sven, 




Een grote dankuwel aan een aantal mensen die me altijd steunen, doctoraat of niet, maar 
die speciaal hebben meegeleefd de afgelopen jaren: 
 
Bedankt aan alle vrienden en vriendinnen voor de gezellige momenten. Christa, Ellen, Evi, 
Nancy en Sarah, de biomedische jaren liggen al ver achter ons maar de vriendschap is nog steeds 
een feit. Dat er nog veel avonturen mogen volgen! Nele, begonnen als een zwemmaatje, maar 
ondertussen ben je zowat mijn trouwste raadgever. Jullie zijn allemaal super! 
Mama en papa, jullie hebben Kim en mij steeds alle kansen geboden om onze dromen 
waar te maken. Mama, bedankt om voor onze kleine bubbel te zorgen. Het is moeilijk te zeggen 
wie er het meest plezier heeft elke donderdag, jij of Maya! Papa, moeilijke tijden liggen achter 
jou, maar mooiere liggen te wachten. Broertje, fantastisch om te zien hoe jij nu je grote ambitie 
nastreeft! Anne, tu me manques, j’éspère que tu nous regarde de temps en temps, comme une 
petite étoile au ciel. 
Meme en pepe, tante Martine, bedankt voor alle steun en interesse. Jullie hebben steeds 
een grote rol gespeeld in het leven van Kim en mij. 
Een grote dankuwel aan de familie Merlier, ik kon me geen warmer nest voorstellen om 
in terecht te komen. Ma en Pa, bedankt om wekelijks jullie huis te veranderen in een waar 
speelparadijs voor Maya! Jos, bedankt om je door het wetenschappelijk Chinees te worstelen. 
Robin, Mimi, Malaika en Aliyah, aan de andere kant van de wereld maar nooit ver uit onze 
gedachten. I look forward to seeing the major mayhem the cousins will unquestionably cause 
when they are re-united!  
 
Thomasje, mijn lieve schat, wie had kunnen denken dat die eerste afspraak in het park tot 
zoveel moois zou leiden. Je was mijn grootste steun tijdens het doctoraat, doorheen alle 
frustraties, hoogtes en laagtes, steeds was je er (en zeker tijdens de allerlaatste loodjes!). Samen 
hebben we al heel wat beleefd en ik kijk vol verwachting uit naar wat er nog komen zal! Het is 
zalig thuiskomen bij jou en Maya, onze liefste en vooral vrolijkste verwezenlijking.  Ik ben 
benieuwd naar onze tweede creatie! 
  
 
 
